{"content":"<li class=\"n-box-item date-title\" data-end=\"1493783999\" data-start=\"1493697600\" data-txt=\"Monday, December 23, 2019\">Tuesday, May  2, 2017</li><li class=\"n-box-item sa-box-item\" data-id=\"3262535\" data-ts=\"1493768313\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OCLR\" target=\"_blank\">OCLR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3262535-oclarominus-8_8-forecasts-china-based-10-revenue-decline\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oclaro -8.8% as it forecasts China-based 10% revenue decline</a></h4><ul>   <li>Oclaro (<a href=\"http://seekingalpha.com/symbol/OCLR\" target=\"_blank\">OCLR</a> <font color='red'>-2%</font>) has <font color='red'>fallen another 8.8%</font> after hours after posting <a href=\"https://seekingalpha.com/news/3262340-oclaro-beats-0_03-beats-revenue\" target=\"_blank\">fiscal Q3 earnings</a> that beat on top and bottom lines but guided low for Q4 sales in an environment where fiber-optics firms are being punished by Chinese demand.</li>    <li>It's guiding to Q4 revenues of $144M-$152M, below consensus expectations for $163.8M. It also sees gross margin (non-GAAP) of 38-41% (vs. an expected 38.1%), and operating income of $27M-$31M.</li>    <li>For Q3, revenues grew more than 60% Y/Y to $162.2M (up 5% Q/Q), and gross margin rose to 41.6% from a year-ago 27.2%.</li>    <li>Non-GAAP operating income increased to $40.5M from a year-ago $4.6M (and Q2's $36.2M).</li>    <li>During April, we saw a significant slowing of demand in China which, coupled with an acceleration of the product transition from 100G CFP related products to the QSFP platform, will cause us to see an approximate 10% sequential decrease in our revenue in the June quarter,\" says CEO Greg Dougherty. But he says gross margin should stay \"around 40 percent as we maintain healthy profitability.</li>    <li><a href=\"https://seekingalpha.com/pr/16818633-oclaro-announces-third-quarter-fiscal-year-2017-financial-results\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3262535\" data-linked=\"Oclaro -8.8% as it forecasts China-based 10% revenue decline\" data-tweet=\"$OCLR - Oclaro -8.8% as it forecasts China-based 10% revenue decline https://seekingalpha.com/news/3262535-oclarominus-8_8-forecasts-china-based-10-revenue-decline?source=tweet\" data-url=\"https://seekingalpha.com/news/3262535-oclarominus-8_8-forecasts-china-based-10-revenue-decline\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3262533\" data-ts=\"1493767183\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPPI\" target=\"_blank\">SPPI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3262533-spectrum-pharmaceuticalsminus-7-off-q1-earnings-miss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Spectrum Pharmaceuticals -7% off Q1 earnings miss</a></h4><ul>   <li>Spectrum Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/SPPI' title='Spectrum Pharmaceuticals, Inc.'>SPPI</a>) is <font color='red'>7% lower</font> postmarket after its <a href=\"https://seekingalpha.com/news/3262325-spectrum-pharmaceuticals-beats-0_06-misses-revenue\" target=\"_blank\">Q1 earnings</a> missed expectations on top and bottom lines.</li>    <li>The company swung to a loss of $11.4M on a non-GAAP basis, from year-ago net income of $0.3M, and its -$0.14 EPS missed an expected -$0.08.</li>    <li>R&amp;D expenses grew to $14.3M from a year-ago $13M, while SG&amp;A expense declined to $15.7M from $16.7M.</li>    <li>Revenue breakout: Net product sales, $25.85M (down 26.7%); license fees and service revenue, $3.3M (down 62.2%).</li>    <li>In pipeline updates, it says it continues to expect to file a BLA next year on Rolontis, which had evaluable patients reduced to 400 in its Phase 3 ADVANCE Pivotal study (75% enrolled); a phase 2 study on Poziotinib recently started at MD Anderson; and a phase 3 study for Qapzola is expected to start enrolling in Q3.</li>    <li><a href=\"https://seekingalpha.com/pr/16818596-spectrum-pharmaceuticals-reports-first-quarter-2017-financial-results-pipeline-update\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3262533\" data-linked=\"Spectrum Pharmaceuticals -7% off Q1 earnings miss\" data-tweet=\"$SPPI - Spectrum Pharmaceuticals -7% off Q1 earnings miss https://seekingalpha.com/news/3262533-spectrum-pharmaceuticalsminus-7-off-q1-earnings-miss?source=tweet\" data-url=\"https://seekingalpha.com/news/3262533-spectrum-pharmaceuticalsminus-7-off-q1-earnings-miss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:19 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3262534\" data-ts=\"1493765844\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APC\" target=\"_blank\">APC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3262534-anadarko-petroleumminus-2_6-after-bigger-expected-q1-loss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Anadarko Petroleum -2.6% after bigger than expected Q1 loss</a></h4><ul>     <li>Anadarko Petroleum (NYSE:<a href='https://seekingalpha.com/symbol/APC' title='Anadarko Petroleum Corporation'>APC</a>) <font color='red'>-2.6%</font>&nbsp;AH after reporting a much bigger than expected <a href=\"https://seekingalpha.com/news/3262388-anadarko-petroleum-misses-0_35-beats-revenue\" target=\"_blank\">Q1 loss</a>, as <a href=\"http://www.reuters.com/article/anadarko-petrol-results-idUSL4N1I44OQ\" target=\"_blank\">sharply higher expenses</a> failed to offset gains from higher crude prices.</li>     <li>APC says its total Q1 costs and expenses surged 53% Y/Y to $3.88B from $2.54B in the year-ago quarter, and exploration expenses rose more than 8x to $1.09B.</li>     <li>Q1 adjusted oil and gas sales volumes averaged 672K boe/day, and APC forecasts total sales volume to average 626K-648K boe/day during Q2 and 644K-655K for FY 2017.</li>     <li>Also, a investigation into the last month's Firestone, Colo., blast that killed two men was <a href=\"http://www.bizjournals.com/denver/news/2017/05/02/investigators-link-fatal-firestone-home-explosion.html\" target=\"_blank\">caused by gas from a line connected to an abandoned APC well</a> in the vicinity, according to a report released today; APC issues a <a href=\"https://seekingalpha.com/pr/16818874-anadarko-issues-statement-regarding-firestone-accident\" target=\"_blank\">statement</a> regretting the incident.</li></ul><div class=\"tiny-share-widget\" data-id=\"3262534\" data-linked=\"Anadarko Petroleum -2.6% after bigger than expected Q1 loss\" data-tweet=\"$APC - Anadarko Petroleum -2.6% after bigger than expected Q1 loss https://seekingalpha.com/news/3262534-anadarko-petroleumminus-2_6-after-bigger-expected-q1-loss?source=tweet\" data-url=\"https://seekingalpha.com/news/3262534-anadarko-petroleumminus-2_6-after-bigger-expected-q1-loss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3262530\" data-ts=\"1493764988\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TWLO\" target=\"_blank\">TWLO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3262530-twilio-tanksminus-30-despite-q1-beat-outlook-disappoints\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Twilio tanks, -30% despite Q1 beat as outlook disappoints</a></h4><ul>   <li>Twilio (<a href=\"http://seekingalpha.com/symbol/TWLO\" target=\"_blank\">TWLO</a> <font color='red'>-1.2%</font>) is the top postmarket decliner on the NYSE, <font color='red'>down 30.5%</font> and shedding nearly a billion dollars in market cap, after its <a href=\"https://seekingalpha.com/news/3262335-twilio-beats-0_02-beats-revenue\" target=\"_blank\">Q1 earnings</a> beat expectations but contained below-consensus guidance for the current quarter and year.</li>    <li>Revenue grew by nearly half again over last year, to $87.4M, and was up 7% from Q4; base revenue rose 62% Y/Y and 7% sequentially to $80.6M.</li>    <li>Net loss on a GAAP basis was $0.16 vs. a year-ago loss of $0.37; non-GAAP EPS was -$0.04 vs. a year-ago -$0.05.</li>    <li>Active customer accounts rose to 40,696 from last year's 28,648.</li>    <li>CEO Jeff Lawson alluded to \"changes in the relationship with our largest customer\" -- likely Uber -- but \"our momentum across the business continues to be strong, with a 42% year over year growth in Active Customer Accounts and a 62% year over year growth in Base Revenue during the quarter.&rdquo;</li>    <li>For Q2, it's guiding to revenue of $85.5M-$87.5M (light of consensus for $87.6M); base revenue of $81.5M-$82.5M; and non-GAAP EPS of -$0.11 to -$0.10 (vs. consensus for -$0.08).</li>    <li>Meanwhile, for the full year it sees revenue of $356M-$362M (below consensus for $369.8M); base revenue of $340M-$343M; and non-GAAP EPS of -$0.30 to -$0.27 (vs. expected -$0.16).</li>    <li><a href=\"https://seekingalpha.com/pr/16818614-twilio-announces-first-quarter-2017-results\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3262530\" data-linked=\"Twilio tanks, -30% despite Q1 beat as outlook disappoints\" data-tweet=\"$TWLO - Twilio tanks, -30% despite Q1 beat as outlook disappoints https://seekingalpha.com/news/3262530-twilio-tanksminus-30-despite-q1-beat-outlook-disappoints?source=tweet\" data-url=\"https://seekingalpha.com/news/3262530-twilio-tanksminus-30-despite-q1-beat-outlook-disappoints\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:43 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>57&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3262529\" data-ts=\"1493764573\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OB\" target=\"_blank\">OB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3262529-onebeacon-to-be-bought-intact-financial-for-1_7b\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">OneBeacon to be bought by Intact Financial for $1.7B</a></h4><ul>     <li>OneBeacon Insurance (NYSE:<a href='https://seekingalpha.com/symbol/OB' title='OneBeacon Insurance Group, LTD'>OB</a>) <a href=\"https://seekingalpha.com/pr/16818744-onebeacon-acquired-intact-financial-corporation-1_7-billion\" target=\"_blank\">agrees to be acquired</a> by Canadian insurer Intact Financial (<a href='https://seekingalpha.com/symbol/IFCZF' title='Intact Financial Corp.'>OTCPK:IFCZF</a>) for US$18.10/share, a 15.3% premium to OB's closing price today, or a total of US$1.7B.</li>     <li>The companies say the combination will create a North American leader in specialty insurance, with more than $1.5B of annual premiums.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3262529\" data-linked=\"OneBeacon to be bought by Intact Financial for $1.7B\" data-tweet=\"$OB $OB $IFCZF - OneBeacon to be bought by Intact Financial for $1.7B https://seekingalpha.com/news/3262529-onebeacon-to-be-bought-intact-financial-for-1_7b?source=tweet\" data-url=\"https://seekingalpha.com/news/3262529-onebeacon-to-be-bought-intact-financial-for-1_7b\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:36 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3262527\" data-ts=\"1493764010\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AKAM\" target=\"_blank\">AKAM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3262527-below-street-guidance-punishes-akamaiminus-13\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Below-Street guidance punishes Akamai, -13%</a></h4><ul>   <li>Akamai (<a href=\"http://seekingalpha.com/symbol/AKAM\" target=\"_blank\">AKAM</a> <font color='green'>+1.7%</font>) managed a beat on top and bottom lines in its <a href=\"https://seekingalpha.com/news/3262317-akamai-beats-0_02-beats-revenue\" target=\"_blank\">Q1 earnings report</a>, but dim guidance on its earnings call has sent shares down the slide in postmarket trading, <font color='red'>-13.1%</font>.</li>    <li>The company's expecting Q2 revenue of $597M-$609M, below consensus for $623.3M, and (non-GAAP) EPS of $0.59-$0.61, below consensus for $0.65.</li>    <li>For its Q1, revenue grew 7.3% thanks to its biggest category (Performance and Security Solutions), dragged slightly by a decline in its gaming vertical.</li>    <li>EPS rose 5% Y/Y to $0.69 on an adjusted basis; headline EPS rose 10% to $0.46.</li>    <li>Revenue by solution category: Performance and Security Solutions, $369M (up 17%); of that, Cloud Security Solutions revenue was $110M (up 36%). Media Delivery Solutions, $187M (down 9%); Services and Support Solutions, $53M (up 15%).</li>    <li>Revenue by division: Web Division, $305M (up 14%); Media Division, $285M (flat); Enterprise and Carrier, $19M (up 24%);</li>    <li><a href=\"https://seekingalpha.com/pr/16818558-akamai-reports-first-quarter-2017-financial-results\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3262527\" data-linked=\"Below-Street guidance punishes Akamai, -13%\" data-tweet=\"$AKAM - Below-Street guidance punishes Akamai, -13% https://seekingalpha.com/news/3262527-below-street-guidance-punishes-akamaiminus-13?source=tweet\" data-url=\"https://seekingalpha.com/news/3262527-below-street-guidance-punishes-akamaiminus-13\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:26 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3262524\" data-ts=\"1493763135\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VIAV\" target=\"_blank\">VIAV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3262524-viaviminus-4_7-fiscal-q3-revenues-come-up-short\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Viavi -4.7% as fiscal Q3 revenues come up short</a></h4><ul>   <li>Viavi Solutions (NASDAQ:<a href='https://seekingalpha.com/symbol/VIAV' title='Viavi Solutions Inc.'>VIAV</a>) is <font color='red'>4.7% lower</font> in postmarket action after mixed <a href=\"https://seekingalpha.com/news/3262336-viavi-solutions-beats-0_02-misses-revenue\" target=\"_blank\">fiscal Q3 earnings</a> where EPS beat expectations but revenues missed narrowly, and the company guided to the light side for the current quarter.</li>    <li>Revenues fell more than 11% after sales in its biggest segment, Network Enablement, declined by 16%.</li>    <li>\"OSP revenue came in above expectations due to stronger than expected anti-counterfeiting demand, and in part offset weaker than expected NSE revenue that was impacted by weaker service provider and enterprise spend,\" says CEO Oleg Khaykin.</li>    <li>Adjusted gross margin of 62.2% was up from a year-ago 61.9%. Operating margin (non-GAAP) was flat at 11.9%.</li>    <li>Revenue by segment: Network Enablement, $103.4M (down 16%); Service Enablement, $28.7M (down 18.5%); Optical Security and Performance Products, $63.9M (up 2.9%).</li>    <li>For its Q4, the company's forecasting revenue of $188M-$204M (below consensus for $205.9M) and EPS of $0.07-$0.09 (vs. consensus for $0.09).</li>    <li><a href=\"https://seekingalpha.com/pr/16818568-viavi-announces-third-quarter-fiscal-2017-results\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3262524\" data-linked=\"Viavi -4.7% as fiscal Q3 revenues come up short\" data-tweet=\"$VIAV - Viavi -4.7% as fiscal Q3 revenues come up short https://seekingalpha.com/news/3262524-viaviminus-4_7-fiscal-q3-revenues-come-up-short?source=tweet\" data-url=\"https://seekingalpha.com/news/3262524-viaviminus-4_7-fiscal-q3-revenues-come-up-short\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:12 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3262511\" data-ts=\"1493761050\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3262511-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li><b>Top gainers, as of 5.25 p.m.:</b> <a href='https://seekingalpha.com/symbol/WTW' title='Weight Watchers International, Inc.'>WTW</a> <font color='green'>+14.2%</font>. <a href='https://seekingalpha.com/symbol/MYGN' title='Myriad Genetics, Inc.'>MYGN</a> <font color='green'>+14.0%</font>. <a href='https://seekingalpha.com/symbol/FEYE' title='FireEye, Inc.'>FEYE</a> <font color='green'>+12.3%</font>. <a href='https://seekingalpha.com/symbol/RYAM' title='Rayonier Advanced Materials'>RYAM</a> <font color='green'>+9.6%</font>. <a href='https://seekingalpha.com/symbol/BGFV' title='Big 5 Sporting Goods Corporation'>BGFV</a> <font color='green'>+8.8%</font>.</li><li><b>Top losers, as of 5.25p.m.:</b> <a href='https://seekingalpha.com/symbol/TWLO' title='Twilio'>TWLO</a> <font color='red'>-28.7%</font>. <a href='https://seekingalpha.com/symbol/IPHI' title='Inphi Corporation'>IPHI</a> <font color='red'>-16.4%</font>. <a href='https://seekingalpha.com/symbol/LCI' title='Lannett Company, Inc'>LCI</a> <font color='red'>-15.2%</font>. <a href='https://seekingalpha.com/symbol/AKAM' title='Akamai Technologies, Inc.'>AKAM</a> <font color='red'>-11.9%</font>. <a href='https://seekingalpha.com/symbol/PBPB' title='Potbelly Corporation'>PBPB</a> <font color='red'>-11.2%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3262511\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$WW $MYGN $FEYE - After Hours Gainers / Losers https://seekingalpha.com/news/3262511-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3262511-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:37 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3262506\" data-ts=\"1493760851\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TXMD\" target=\"_blank\">TXMD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3262506-therapeuticsmd-eps-in-line-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TherapeuticsMD EPS in-line, misses on revenue</a></h4><ul><li>TherapeuticsMD (NYSEMKT:<a href='https://seekingalpha.com/symbol/TXMD' title='TherapeuticsMD'>TXMD</a>): Q1 EPS of -$0.11 in-line.</li><li>Revenue of $3.96M (-19.7% Y/Y) <font color='red'>misses by $1.27M</font>.</li><li>Shares <font color='green'>+2.49%</font> AH.</li><li><a href='https://seekingalpha.com/pr/16818780-therapeuticsmd-announces-first-quarter-2017-financial-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3262506\" data-linked=\"TherapeuticsMD EPS in-line, misses on revenue\" data-tweet=\"$TXMD - TherapeuticsMD EPS in-line, misses on revenue https://seekingalpha.com/news/3262506-therapeuticsmd-eps-in-line-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3262506-therapeuticsmd-eps-in-line-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:34 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3262505\" data-ts=\"1493760357\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FSLR\" target=\"_blank\">FSLR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3262505-first-solarplus-8-on-big-q1-beat-upside-full-year-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">First Solar +8% on big Q1 beat, upside full-year guidance</a></h4><ul>     <li>First Solar (NASDAQ:<a href='https://seekingalpha.com/symbol/FSLR' title='First Solar, Inc.'>FSLR</a>) <font color='green'>+8.2%</font>&nbsp;AH after routing <a href=\"https://seekingalpha.com/news/3262331-first-solar-beats-0_38-beats-revenue\" target=\"_blank\">Q1 earnings</a> and revenue expectations, and guiding full-year results above Wall Street consensus.</li>     <li>FSLR sees FY 2017 EPS of $0.25-$0.75 vs. its prior outlook of flat to $0.50 and $0.29 analyst consensus estimate, and revenues of $2.85B-$2.95B from previous guidance of $2.8B-$2.9B and $2.79B consensus.</li><li>For the full year, FSLR also forecasts gross margin of 12.5%-14.5% from 11%-13% prior; net cash balance of $1.5B-$1.7B vs. $1.4B-$1.6B prior, and operating cash flow of $350M-$450M vs. $250M-$350M prior; estimates for total GW and capex remain unchanged at 2.4-2.6 and $525M-$625M, respectively.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3262505\" data-linked=\"First Solar +8% on big Q1 beat, upside full-year guidance\" data-tweet=\"$FSLR - First Solar +8% on big Q1 beat, upside full-year guidance https://seekingalpha.com/news/3262505-first-solarplus-8-on-big-q1-beat-upside-full-year-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3262505-first-solarplus-8-on-big-q1-beat-upside-full-year-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:25 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>45&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3262496\" data-ts=\"1493760048\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FEYE\" target=\"_blank\">FEYE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3262496-fireeyeplus-13-on-q1-beat-sunny-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FireEye +13% on Q1 beat, sunny guidance</a></h4><ul>   <li>FireEye (NASDAQ:<a href='https://seekingalpha.com/symbol/FEYE' title='FireEye, Inc.'>FEYE</a>) came out of a halt and is <font color='green'>up 13%</font> in postmarket trade after its <a href=\"https://seekingalpha.com/news/3262326-fireeye-beats-0_17-beats-revenue\" target=\"_blank\">Q1 earnings</a> showed a much smaller loss than expected and revenue beat the Street as well.</li>    <li>The company more than halved its net loss on a GAAP basis (to $0.48 from $0.98). On a non-GAAP basis, net loss of $0.09 was much narrower than a year-ago loss of $0.47.</li>    <li>Cash flow from operations was similarly above guidance at -$17M, vs. a year-ago -$22.5M. Billings were down 18% Y/Y to $152.4M, but came in above the guidance range of $130M-$150M.</li>    <li>Revenue breakout: Product, $23.7M (down 29.6%); Subscription and services, $150M (up 11.7%).</li>    <li>For Q2, it sees revenue of $173M-$179M (above consensus for $172.7M), billings of $155M-$175M, non-GAAP gross margin of about 72%, a net loss of $0.10 to $0.14 (above consensus for a net loss of $0.15) and cash flow from operations ranging from -$17M to -$27M.</li>    <li>For the full year, it's guiding to revenue of $724M-$736M (above expectations for $722.8M), billings of $745M-$775M, a non-GAAP net loss of $0.26 to $0.36 (above consensus for a loss of $0.48), and positive cash flow from operations of $1M-$10M.</li>    <li><a href=\"https://seekingalpha.com/pr/16818572-fireeye-reports-guidance-revenue-billings-improved-operating-margins-first-quarter-2017\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3262496\" data-linked=\"FireEye +13% on Q1 beat, sunny guidance\" data-tweet=\"$FEYE - FireEye +13% on Q1 beat, sunny guidance https://seekingalpha.com/news/3262496-fireeyeplus-13-on-q1-beat-sunny-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3262496-fireeyeplus-13-on-q1-beat-sunny-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:20 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3262475\" data-ts=\"1493759017\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PZZA\" target=\"_blank\">PZZA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3262475-papa-johns-beats-0_03-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Papa John&#39;s beats by $0.03, beats on revenue</a></h4><ul><li>Papa John's (NASDAQ:<a href='https://seekingalpha.com/symbol/PZZA' title='Papa John&#39;s International, Inc.'>PZZA</a>): Q1 EPS of $0.77 <font color='green'>beats by $0.03</font>.</li><li>Revenue of $449.27M (+4.8% Y/Y) <font color='green'>beats by $10.56M</font>.</li><li>Shares <font color='green'>+1.9%</font> AH.</li><li><a href='https://seekingalpha.com/pr/16818831-papa-john-s-announces-first-quarter-2017-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3262475\" data-linked=\"Papa John&#39;s beats by $0.03, beats on revenue\" data-tweet=\"$PZZA - Papa John&#39;s beats by $0.03, beats on revenue https://seekingalpha.com/news/3262475-papa-johns-beats-0_03-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3262475-papa-johns-beats-0_03-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:03 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3262463\" data-ts=\"1493758517\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAPL\" target=\"_blank\">AAPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3262463-appleminus-1_8-revenues-iphones-miss-despite-returns-boost\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Apple -1.8% as revenues, iPhones miss, despite returns boost</a></h4><ul>   <li>Apple (NASDAQ:<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a>) is <font color='red'>off 1.8%</font> after posting a <a href=\"https://seekingalpha.com/news/3262438-apple-beats-0_08-misses-revenue\" target=\"_blank\">fiscal Q2 report</a> where investors' eyes were thought to be looking past numbers toward a dividend hike and any information about a fall iPhone refresh, though the company missed on revenues and iPhone shipment expectations.</li>    <li>In updating its capital allocation, the company boosted its dividend 10.5% and added $35B to its buyback authorization.</li>    <li><b>Revenue by product lines:</b> iPhone, $33.25B (up 1%); iPad, $3.9B (down 12%); Mac, $5.84B (up 14%). Services revenue (iTunes, App Store, Apple Music, AppleCare, Apple Pay) $7.04B (up 18%); Other products (Apple Watch, Apple TV, Beats, iPod) $2.87B (up 31%).</li>    <li><b>Revenue by region:</b> Americas, $21.16B (up 11%); Europe, $12.7B (up 10%); Greater China, $10.73B (down 14%); Japan, $4.49B (up 5%); Rest of AP, $3.8B (up 20%).</li>    <li><b>Financials:</b> The overall capital return program gets a $50B boost and has its timeline extended by four quarters. The company plans to spend $300B by the end of March 2019 in the expanded program. Buyback authorization goes to $210B from $175B; dividend up 10.5% to $0.63/share.</li>    <li>It's guiding to Q3 revenue of $43.5B-$45.5B (vs. consensus for $45.59B); gross margin of 37.5-38.5%; opex of $6.6B-$6.7B; other income of $450M; and a tax rate of 25.5%.</li>    <li><a href=\"http://www.apple.com/investor/earnings-call/\" target=\"_blank\">Conference call</a> to come at 5 p.m. ET.</li><li><a href=\"http://seekingalpha.com/pr/16818777-apple-reports-second-quarter-results\" target=\"_blank\">Apple press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3262463\" data-linked=\"Apple -1.8% as revenues, iPhones miss, despite returns boost\" data-tweet=\"$AAPL - Apple -1.8% as revenues, iPhones miss, despite returns boost https://seekingalpha.com/news/3262463-appleminus-1_8-revenues-iphones-miss-despite-returns-boost?source=tweet\" data-url=\"https://seekingalpha.com/news/3262463-appleminus-1_8-revenues-iphones-miss-despite-returns-boost\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:55 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>66&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3262452\" data-ts=\"1493758038\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/USO\" target=\"_blank\">USO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3262452-oil-rises-after-hours-on-bullish-inventory-number\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oil rises after hours on bullish inventory number</a></h4><ul><li>The API reports a 4.16M draw from crude inventories last week vs. the 3.5M decline expected for the EIA report tomorrow morning.</li><li>Gasoline stocks fell 1.93M barrels; distillates fell 436K barrels.</li><li><a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a>&nbsp;<font color='green'>+0.8%</font>&nbsp;after hours</li></ul><div class=\"tiny-share-widget\" data-id=\"3262452\" data-linked=\"Oil rises after hours on bullish inventory number\" data-tweet=\"$USO - Oil rises after hours on bullish inventory number https://seekingalpha.com/news/3262452-oil-rises-after-hours-on-bullish-inventory-number?source=tweet\" data-url=\"https://seekingalpha.com/news/3262452-oil-rises-after-hours-on-bullish-inventory-number\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3262429\" data-ts=\"1493757415\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QUAD\" target=\"_blank\">QUAD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3262429-quad-graphics-beats-0_14-revenue-in-line\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Quad/Graphics beats by $0.14,  revenue in-line</a></h4><ul><li>Quad/Graphics (NYSE:<a href='https://seekingalpha.com/symbol/QUAD' title='Quad/Graphics, Inc.'>QUAD</a>): Q1 EPS of $0.52 <font color='green'>beats by $0.14</font>.</li><li>Revenue of $998.6M (-4.0% Y/Y) in-line.</li><li>Shares <font color='green'>+6.05%</font>.</li><li><a href='https://seekingalpha.com/pr/16818776-quad-graphics-reports-first-quarter-2017-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3262429\" data-linked=\"Quad/Graphics beats by $0.14,  revenue in-line\" data-tweet=\"$QUAD - Quad/Graphics beats by $0.14, revenue in-line https://seekingalpha.com/news/3262429-quad-graphics-beats-0_14-revenue-in-line?source=tweet\" data-url=\"https://seekingalpha.com/news/3262429-quad-graphics-beats-0_14-revenue-in-line\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:36 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3262404\" data-ts=\"1493756712\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WTW\" target=\"_blank\">WTW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3262404-weight-watchers-beats-0_03-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Weight Watchers beats by $0.03, beats on revenue</a></h4><ul><li>Weight Watchers (NYSE:<a href='https://seekingalpha.com/symbol/WTW' title='Weight Watchers International, Inc.'>WTW</a>): Q1 EPS of -$0.01 <font color='green'>beats by $0.03</font>.</li><li>Revenue of $329.1M (+7.2% Y/Y) <font color='green'>beats by $7.2M</font>.</li><li>Shares <font color='green'>+11.61%</font>.</li><li><a href='https://seekingalpha.com/pr/16818706-weight-watchers-announces-first-quarter-2017-results-raises-full-year-2017-guidance'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3262404\" data-linked=\"Weight Watchers beats by $0.03, beats on revenue\" data-tweet=\"$WTW $WW - Weight Watchers beats by $0.03, beats on revenue https://seekingalpha.com/news/3262404-weight-watchers-beats-0_03-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3262404-weight-watchers-beats-0_03-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:25 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3262390\" data-ts=\"1493756456\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ETSY\" target=\"_blank\">ETSY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3262390-etsy-down-14_8-ceo-cto-exit-company\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Etsy down 14.8% as CEO, CTO exit company</a></h4><ul>   <li>Etsy (<a href=\"http://seekingalpha.com/symbol/ETSY\" target=\"_blank\">ETSY</a> <font color='green'>+3%</font>) has <font color='red'>tumbled 14.8%</font> in postmarket trade amid news (along with earnings) that CEO/Chairman Chad Dickerson will <a href=\"https://seekingalpha.com/pr/16818694-etsy-inc-reports-first-quarter-2017-financial-results\" target=\"_blank\">step down from his posts</a>.</li>    <li>Josh Silverman has been named the new CEO, effective tomorrow. Fred Wilson, lead independent director, will become chairman.</li>    <li>Dickerson will serve in an advisory role until May 31.</li>    <li>In other executive shuffles, Chief Technology Officer John Allspaw is leaving the company, to be succeeded by Mike Brittain, VP of Engineering. Allspaw will also serve as an advisor until May 31.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3262192-etsy-plus-3_5-percent-targeted-investor-strategic-review\" target=\"_blank\">Etsy +3.5%, targeted by investor for strategic review</a> (May 2 2017)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3262390\" data-linked=\"Etsy down 14.8% as CEO, CTO exit company\" data-tweet=\"$ETSY - Etsy down 14.8% as CEO, CTO exit company https://seekingalpha.com/news/3262390-etsy-down-14_8-ceo-cto-exit-company?source=tweet\" data-url=\"https://seekingalpha.com/news/3262390-etsy-down-14_8-ceo-cto-exit-company\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:20 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3262379\" data-ts=\"1493756294\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MDLZ\" target=\"_blank\">MDLZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3262379-margins-improve-mondelez-international\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Margins improve at Mondelez International</a></h4><ul><li>Mondelez International (NASDAQ:<a href='https://seekingalpha.com/symbol/MDLZ' title='Mondelēz International, Inc.'>MDLZ</a>) tops <a href=\"https://seekingalpha.com/pr/16818552-mondelez-international-reports-q1-results\" target=\"_blank\">Q1</a> estimates after showing improved margin rates.</li><li>Organic revenue was up 0.6% during the quarter, with all regions showing positive growth except North America.</li><li>Volume/mix was down 0.5% across segments, offset by a 1.1% increase in prices.</li><li>Looking ahead, Mondelez maintains prior guidance for 1% organic revenue growth in 2017 and double-digit EPS growth.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3262316-mondelez-beats-0_03-beats-revenue\" target=\"_blank\">Mondelēz beats by $0.03, beats on revenue</a> (May 2)</li><li>MDLZ&nbsp;<font color='green'>+2.38%</font>&nbsp;AH to $44.81.</li></ul><div class=\"tiny-share-widget\" data-id=\"3262379\" data-linked=\"Margins improve at Mondelez International\" data-tweet=\"$MDLZ - Margins improve at Mondelez International https://seekingalpha.com/news/3262379-margins-improve-mondelez-international?source=tweet\" data-url=\"https://seekingalpha.com/news/3262379-margins-improve-mondelez-international\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3262374\" data-ts=\"1493756214\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FTR\" target=\"_blank\">FTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3262374-frontier-communicationsminus-3_3-on-worse-q1-loss-expected\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Frontier Communications -3.3% on worse Q1 loss than expected</a></h4><ul>   <li>Frontier Communications (<a href=\"http://seekingalpha.com/symbol/FTR\" target=\"_blank\">FTR</a> <font color='green'>+4.9%</font>) has reversed course after hours, <font color='red'>-3.3%</font>, after posting a <a href=\"https://seekingalpha.com/news/3262323-frontier-communications-misses-0_03-beats-revenue\" target=\"_blank\">worse-than-expected loss for Q1</a>.</li>    <li>EBITDA came to $923M, short of an expected $926.5M. Net loss overall narrowed to $75M before preferred-stock dividends, from last year's loss of $186M.</li>    <li>Residential customers shrank to 4.74M from last quarter's $4.89M; monthly churn rose to 2.37% from $2.08%, and average monthly residential revenue per customer rose to $80.62 from $80.33.</li>    <li>On the business side, customers fell to 484,000 from 502,000; broadband subs shrank to 4.16M from 4.27M adn video subs fell to 1.065M from 1.145M.</li>    <li>Net cash from operations was $300M; adjusted free cash flow was $175M. Dividend payout ratio was up to 71% from last quarter's 39%.</li>    <li>It's reiterated full-year guidance for adjusted free cash flow of $800M-$1B, capex of $1B-$1.25B, and cash taxes of $0 to $50M.</li>    <li><a href=\"http://www.frontier.com/ir\" target=\"_blank\">Conference call</a> to come at 4:30 p.m. ET.</li>    <li><a href=\"https://seekingalpha.com/pr/16818563-frontier-communications-reports-2017-first-quarter-results\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3262374\" data-linked=\"Frontier Communications -3.3% on worse Q1 loss than expected\" data-tweet=\"$FTR - Frontier Communications -3.3% on worse Q1 loss than expected https://seekingalpha.com/news/3262374-frontier-communicationsminus-3_3-on-worse-q1-loss-expected?source=tweet\" data-url=\"https://seekingalpha.com/news/3262374-frontier-communicationsminus-3_3-on-worse-q1-loss-expected\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:16 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3262356\" data-ts=\"1493755972\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CGNT\" target=\"_blank\">CGNT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3262356-cogentix-medical-misses-0_01-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cogentix Medical misses by $0.01, misses on revenue</a></h4><ul><li>Cogentix Medical (NASDAQ:<a href='https://seekingalpha.com/symbol/CGNT' title='Cogentix Medical, Inc.'>CGNT</a>): Q1 EPS of -$0.02 <font color='red'>misses by $0.01</font>.</li><li>Revenue of $13M (+6.5% Y/Y) <font color='red'>misses by $0.14M</font>.</li><li>Shares <font color='green'>+1.1%</font>.</li><li><a href='https://seekingalpha.com/pr/16818588-cogentix-medical-reports-first-quarter-operating-results-urology-revenue-11-percent'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3262356\" data-linked=\"Cogentix Medical misses by $0.01, misses on revenue\" data-tweet=\"$CGNT - Cogentix Medical misses by $0.01, misses on revenue https://seekingalpha.com/news/3262356-cogentix-medical-misses-0_01-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3262356-cogentix-medical-misses-0_01-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3262349\" data-ts=\"1493755828\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GILD\" target=\"_blank\">GILD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3262349-gileadminus-2_3-after-sales-and-profits-come-in-light\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gilead -2.3% after sales and profits come in light</a></h4><ul><li>Q1 adjusted income of $2.9B or $2.23 per share vs. $4.3B and $3.03 one year ago. Estimates were for $2.28.</li><li>Revenue of $6.51B shy of estimates of $6.63B.</li><li>Harvoni sales of $1.37B about inline with expectations; Sovaldi sales of $313M vs. $380.3M estimate; Epclusa sales of $892M vs. $898M estimate; Truvada sales of $714M vs. $815M estimate; Genvoya sales of $769M vs. $645M estimate.</li><li>Full-year revenue guidance of $22.5B-$24.5B is reiterated.</li><li><a href=\"http://www.gilead.com/investors\" target=\"_blank\">Conference call at 4:30 ET</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3262330-gilead-sciences-misses-0_05-misses-revenue\" target=\"_blank\">Gilead Sciences misses by $0.05, misses on revenue</a> (May 2)</li><li><a href='https://seekingalpha.com/symbol/GILD' title='Gilead Sciences, Inc.'>GILD</a><font color='red'> -2.3%</font>&nbsp;after hours</li></ul><div class=\"tiny-share-widget\" data-id=\"3262349\" data-linked=\"Gilead -2.3% after sales and profits come in light\" data-tweet=\"$GILD - Gilead -2.3% after sales and profits come in light https://seekingalpha.com/news/3262349-gileadminus-2_3-after-sales-and-profits-come-in-light?source=tweet\" data-url=\"https://seekingalpha.com/news/3262349-gileadminus-2_3-after-sales-and-profits-come-in-light\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>88&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3262331\" data-ts=\"1493755566\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FSLR\" target=\"_blank\">FSLR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3262331-first-solar-beats-0_38-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">First Solar beats by $0.38, beats on revenue</a></h4><ul><li>First Solar (NASDAQ:<a href='https://seekingalpha.com/symbol/FSLR' title='First Solar, Inc.'>FSLR</a>): Q1 EPS of $0.25 <font color='green'>beats by $0.38</font>.</li><li>Revenue of $892M (+5.1% Y/Y) <font color='green'>beats by $224.2M</font>.</li><li>Shares <font color='green'>+8%</font>.</li><li><a href='https://seekingalpha.com/pr/16818599-first-solar-inc-announces-first-quarter-2017-financial-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3262331\" data-linked=\"First Solar beats by $0.38, beats on revenue\" data-tweet=\"$FSLR - First Solar beats by $0.38, beats on revenue https://seekingalpha.com/news/3262331-first-solar-beats-0_38-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3262331-first-solar-beats-0_38-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>30&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3262316\" data-ts=\"1493755310\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MDLZ\" target=\"_blank\">MDLZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3262316-mondelez-beats-0_03-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mondelēz beats by $0.03, beats on revenue</a></h4><ul><li>Mondelēz (NASDAQ:<a href='https://seekingalpha.com/symbol/MDLZ' title='Mondelēz International, Inc.'>MDLZ</a>): Q1 EPS of $0.53 <font color='green'>beats by $0.03</font>.</li><li>Revenue of $6.41B (-0.8% Y/Y) <font color='green'>beats by $40M</font>.</li><li>Shares <font color='green'>+2.58%</font>.</li><li><a href='https://seekingalpha.com/pr/16818552-mondelez-international-reports-q1-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3262316\" data-linked=\"Mondelēz beats by $0.03, beats on revenue\" data-tweet=\"$MDLZ - Mondelēz beats by $0.03, beats on revenue https://seekingalpha.com/news/3262316-mondelez-beats-0_03-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3262316-mondelez-beats-0_03-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3262306\" data-ts=\"1493751620\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3262306-technology-top-gainers-losers-of-3-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top Gainers / Losers as of 3:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/ANGI' title='ANGI Homeservices Inc.'>ANGI</a> <font color='green'>+63%</font>. <a href='https://seekingalpha.com/symbol/IAC' title='IAC/InterActiveCorp'>IAC</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/QBAK' title='Qualstar Corporation'>QBAK</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/NTNX' title='Nutanix'>NTNX</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/JCS' title='Communications Systems, Inc.'>JCS</a> <font color='green'>+7%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/AMD' title='Advanced Micro Devices, Inc.'>AMD</a> <font color='red'>-23%</font>. <a href='https://seekingalpha.com/symbol/IIVI' title='II-VI Incorporated'>IIVI</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/MTBC' title='Medical Transcription Billing'>MTBC</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/CBAK-OLD' title='China BAK Battery, Inc.'>CBAK-OLD</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/WSTC' title='West Corporation'>WSTC</a> <font color='red'>-10%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3262306\" data-linked=\"Technology - Top Gainers / Losers as of 3:00 pm\" data-tweet=\"$ANGI $IAC $QBAK - Technology - Top Gainers / Losers as of 3:00 pm https://seekingalpha.com/news/3262306-technology-top-gainers-losers-of-3-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3262306-technology-top-gainers-losers-of-3-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3262305\" data-ts=\"1493750942\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/COP\" target=\"_blank\">COP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3262305-conocophillips-surprise-q1-loss-not-big-deal-analyst-says\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ConocoPhillips&#39; surprise Q1 loss not a big deal, analyst says</a></h4><ul>     <li>ConocoPhillips (<a href='https://seekingalpha.com/symbol/COP' title='ConocoPhillips'>COP</a> <font color='red'>-2.3%</font>) is lower after reporting a <a href=\"https://seekingalpha.com/news/3262110-conocophillips-ticks-lower-surprise-adjusted-q1-loss\" target=\"_blank\">Q1 loss</a>, hurt in part by <a href=\"http://www.reuters.com/article/us-conocophillips-results-idUSKBN17Y16A\" target=\"_blank\">higher than expected operating costs</a>, but at least one analyst - Wells Fargo analyst Roger Read - is <a href=\"http://www.barrons.com/articles/conocophillips-why-the-fuss-1493741185\" target=\"_blank\">not at all rattled</a> by the unexpected loss.</li><li>Read writes that the EPS miss \"could be a minor negative, but both production and operating cash flow exceeded our expectations while full year production guidance was unchanged.\"</li>     <li>The cash flow beat \"came in spite of a much larger negative deferred tax impact, which speaks to underlying performance of COP,\" according to Read.</li>     <li>In today's earnings conference call, CFO Don Wallette Jr. said Q1 results included a $200M loss from a currency hedge tied to the British pound and a ~$100M benefit from a tax loss carry forward.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3262305\" data-linked=\"ConocoPhillips&#39; surprise Q1 loss not a big deal, analyst says\" data-tweet=\"$COP - ConocoPhillips&#39; surprise Q1 loss not a big deal, analyst says https://seekingalpha.com/news/3262305-conocophillips-surprise-q1-loss-not-big-deal-analyst-says?source=tweet\" data-url=\"https://seekingalpha.com/news/3262305-conocophillips-surprise-q1-loss-not-big-deal-analyst-says\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:49 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3262300\" data-ts=\"1493750493\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LVLT\" target=\"_blank\">LVLT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3262300-centurylink-closes-on-2_3b-sale-of-data-center-business\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CenturyLink closes on $2.3B sale of its data center business</a></h4><ul>   <li>CenturyLink (<a href=\"http://seekingalpha.com/symbol/CTL\" target=\"_blank\">CTL</a> <font color='green'>+2.4%</font>) has <a href=\"https://seekingalpha.com/pr/16817800-centurylink-completes-sale-data-centers-colocation-business-consortium-led-bc-partners-medina\" target=\"_blank\">closed on the sale</a> of its data centers/co-location business to a consortium led by BC Partners and Medina Capital Advisors.</li>    <li>The company had <a href=\"https://seekingalpha.com/news/3221319-centurylink-deal-sell-data-centers-near-2_3b\" target=\"_blank\">come to a deal</a> near $2.3B in November to sell the business, with the intent to use the proceeds to partly fund its acquisition of Level 3 (NASDAQ:<a href='https://seekingalpha.com/symbol/LVLT' title='Level 3 Communications, Inc.'>LVLT</a>).</li>    <li>CenturyLink has gotten about $1.868B in pre-tax net cash, along with about 10% in the buyers' new infrastructure company, Cyxtera Technologies.</li>    <li>Along with that stake, CenturyLink will hold on to hosting and cloud assets, and will keep offering co-location services through its relationship with Cyxtera.</li>    <li>Cyxtera, meanwhile, takes ownership of 57 data centers, with 195 MW of power across 2.6M square feet of raised floor, along with about 700 CenturyLink employees.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3262300\" data-linked=\"CenturyLink closes on $2.3B sale of its data center business\" data-tweet=\"$LVLT $LVLT $CTL - CenturyLink closes on $2.3B sale of its data center business https://seekingalpha.com/news/3262300-centurylink-closes-on-2_3b-sale-of-data-center-business?source=tweet\" data-url=\"https://seekingalpha.com/news/3262300-centurylink-closes-on-2_3b-sale-of-data-center-business\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:41 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3262297\" data-ts=\"1493750190\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MLM\" target=\"_blank\">MLM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3262297-construction-stocks-rise-on-martin-marietta-earnings-infrastructure-hopes\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Construction stocks rise on Martin Marietta earnings, infrastructure hopes</a></h4><ul>     <li><a href=\"http://www.cnbc.com/2017/05/02/construction-stocks-soar-on-strong-martin-marietta-earnings-infrastructure-hopes.html\" target=\"_blank\">Construction stocks are on the move</a> after several companies reported better than expected earnings and U.S. Transportation Secretary Chao says details on the Trump administration's infrastructure plan will come \"pretty soon.\"</li>     <li>Martin Marietta Materials (<a href='https://seekingalpha.com/symbol/MLM' title='Martin Marietta Materials Inc.'>MLM</a> <font color='green'>+7.2%</font>) routed Wall Street's <a href=\"https://seekingalpha.com/news/3262066-martin-marietta-materials-beats-0_20-beats-revenue\" target=\"_blank\">Q1 earnings</a> estimates, and CEO&nbsp;Ward Nye says the company is \"highly confident that we are in a multi-year construction  recovery. and that Martin Marietta is particularly well positioned to  benefit from the expected increased demand.\"</li>     <li>MLM  reaffirms FY 2017 guidance, seeing revenues of $3.75B-$3.95B vs. $3.88 analyst consensus estimate and EBITDA of $1.05B-$1.13B; aggregate product line end-use for the infrastructure market is expected to increase in the mid-single digits.</li><li>However, Flowserve (<a href='https://seekingalpha.com/symbol/FLS' title='Flowserve Corporation'>FLS</a> <font color='green'>+0.2%</font>) has shed sizeable early gains racked up after beating <a href=\"https://seekingalpha.com/news/3261868-flowserve-beats-0_06-beats-revenue\" target=\"_blank\">Q1 earnings</a> estimates; it also  reaffirms FY 2017 guidance, seeing EPS of $1.55-$1.85 vs. $1.75 consensus.</li><li>Also: <a href='https://seekingalpha.com/symbol/VMC' title='Vulcan Materials Company'>VMC</a> <font color='green'>+3.5%</font>, <a href='https://seekingalpha.com/symbol/SUM' title='Summit Materials'>SUM</a> <font color='green'>+1.5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3262297\" data-linked=\"Construction stocks rise on Martin Marietta earnings, infrastructure hopes\" data-tweet=\"$MLM $MLM $FLS - Construction stocks rise on Martin Marietta earnings, infrastructure hopes https://seekingalpha.com/news/3262297-construction-stocks-rise-on-martin-marietta-earnings-infrastructure-hopes?source=tweet\" data-url=\"https://seekingalpha.com/news/3262297-construction-stocks-rise-on-martin-marietta-earnings-infrastructure-hopes\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:36 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3262296\" data-ts=\"1493750152\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MOH\" target=\"_blank\">MOH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3262296-molina-be-double-new-leadership-stifel\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Molina could be a double with new leadership - Stifel</a></h4><ul><li><a href=\"https://twitter.com/thenotablecalls\" target=\"_blank\">via Notable Calls</a></li><li>Should new management drive a 2% net margin by 2019 - similar to what peers are seeing - Molina (NYSE:<a href='https://seekingalpha.com/symbol/MOH' title='Molina Healthcare, Inc.'>MOH</a>) EPS could near $7.50 per share, says Stifel</li><li>Slapping a 15x multiple on that - reasonable for a Medicaid MCO - means a $110 share price.</li><li>Stifel also notes that the now-exited Molina family members were the biggest barriers to a sale of the company.</li><li>Taking a different view, Wells Fargo says not to chase the stock at these levels.</li><li>MOH&nbsp;<font color='green'>+14.9%</font>&nbsp;to $58.37</li><li>Previously: <a href=\"https://seekingalpha.com/news/3262279-molina-healthcare-ousts-ceo-cfo-performance-updated\" target=\"_blank\">Molina Healthcare ousts CEO, CFO for performance (updated)</a> (May 2)</li></ul><div class=\"tiny-share-widget\" data-id=\"3262296\" data-linked=\"Molina could be a double with new leadership - Stifel\" data-tweet=\"$MOH - Molina could be a double with new leadership - Stifel https://seekingalpha.com/news/3262296-molina-be-double-new-leadership-stifel?source=tweet\" data-url=\"https://seekingalpha.com/news/3262296-molina-be-double-new-leadership-stifel\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:35 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3262295\" data-ts=\"1493749376\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3262295-oil-slumps-to-lowest-level-of-2017\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oil slumps to lowest level of 2017</a></h4><ul><li>There was some bullish news earlier today <a href=\"https://seekingalpha.com/news/3262195-opec-deepens-production-cuts-compliance-improves\" target=\"_blank\">as OPEC reported</a> a fourth consecutive month of oil output. Compliance, however, fell to 90% from 92% thanks to more production than expected from Angola and UAE. Libya said production rose to 760K bpd - the highest since Dec. 2014 - and the country plans to continue to boost output.</li><li>Then there's U.S. output - it's on the rise, hitting its strongest level since August 2015.</li><li>There's also comments from Saudi Crown Prince bin Salman on the wires, noting the unprecedented nature of the OPEC/Russia production cut deal. The upside for oil, he says, is $55 per barrel, and the downside $45.</li><li>WTI crude<font color='red'> -2.35%</font>&nbsp;to $47.69 per barrel.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a>, <a href='https://seekingalpha.com/symbol/OIL' title='iPath S&P Crude Oil Total Return Index ETN'>OIL</a>, <a href='https://seekingalpha.com/symbol/UCO' title='ProShares Ultra Bloomberg Crude Oil ETF'>UCO</a>, <a href='https://seekingalpha.com/symbol/SCO' title='ProShares UltraShort Bloomberg Crude Oil ETF'>SCO</a>, <a href='https://seekingalpha.com/symbol/BNO' title='The United States Brent Oil ETF, LP'>BNO</a>, <a href='https://seekingalpha.com/symbol/DBO' title='PowerShares DB Oil ETF'>DBO</a>, <a href='https://seekingalpha.com/symbol/DTO' title='DB Crude Oil Double Short ETN'>DTO</a>, <a href='https://seekingalpha.com/symbol/UGA' title='The United States Gasoline ETF, LP'>UGA</a>, <a href='https://seekingalpha.com/symbol/USL' title='The United States 12 Month Oil ETF, LP'>USL</a>, <a href='https://seekingalpha.com/symbol/DNO' title='The United States Short Oil ETF, LP'>DNO</a>, <a href='https://seekingalpha.com/symbol/OLO' title='DB Crude Oil Long ETN'>OLO</a>, <a href='https://seekingalpha.com/symbol/UHN' title='The United States Diesel-Heating Oil ETF, LP'>UHN</a>, <a href='https://seekingalpha.com/symbol/SZO' title='DB Crude Oil Short ETN'>SZO</a>, <a href='https://seekingalpha.com/symbol/OLEM' title='iPath Pure Beta Crude Oil ETN'>OLEM</a>, <a href='https://seekingalpha.com/symbol/DWT' title='VelocityShares 3x Inverse Crude Oil ETN'>DWT</a>, <a href='https://seekingalpha.com/symbol/OILK' title='ProShares K-1 Free Crude Oil Strategy ETF'>OILK</a>, <a href='https://seekingalpha.com/symbol/OILX' title='Etracs S&P GSCI Crude Oil Total Return Index ETN'>OILX</a>, <a href='https://seekingalpha.com/symbol/USOI' title='Credit Suisse Crude Oil Shares Covered Call ETN'>USOI</a>, <a href='https://seekingalpha.com/symbol/UWT' title='VelocityShares 3X Long Crude ETN'>UWT</a>, <a href='https://seekingalpha.com/symbol/WTID' title='ProShares Daily 3x Inverse Crude ETN'>WTID</a>, <a href='https://seekingalpha.com/symbol/WTIU' title='ProShares Daily 3x Long Crude ETN'>WTIU</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3262295\" data-linked=\"Oil slumps to lowest level of 2017\" data-tweet=\"$USO $OIL $UCO - Oil slumps to lowest level of 2017 https://seekingalpha.com/news/3262295-oil-slumps-to-lowest-level-of-2017?source=tweet\" data-url=\"https://seekingalpha.com/news/3262295-oil-slumps-to-lowest-level-of-2017\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>43&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3262292\" data-ts=\"1493748885\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CHGG\" target=\"_blank\">CHGG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3262292-chegg-soars-after-earnings-shine\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chegg soars after earnings shine</a></h4><ul><li>Chegg (<a href='https://seekingalpha.com/symbol/CHGG' title='Chegg, Inc.'>CHGG</a> <font color='green'>+27.7%</font>) pops after the company tops Q1 estimates.</li><li>Looking ahead, Chegg expects 2017 revenue of $235-$240M and adjusted EBITDA of $38-$40M.</li><li>Earlier today, Raymond James upgraded Chegg to Outperform, however today's runup of shares has pushed right up against RJ's price target of $12.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3261832-chegg-beats-0_03-beats-revenue\" target=\"_blank\">Chegg beats by $0.03, beats on revenue</a> (May 1)</li></ul><div class=\"tiny-share-widget\" data-id=\"3262292\" data-linked=\"Chegg soars after earnings shine\" data-tweet=\"$CHGG - Chegg soars after earnings shine https://seekingalpha.com/news/3262292-chegg-soars-after-earnings-shine?source=tweet\" data-url=\"https://seekingalpha.com/news/3262292-chegg-soars-after-earnings-shine\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3262290\" data-ts=\"1493748043\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3262290-energy-materials-top-gainers-losers-of-2-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top Gainers / Losers as of 2:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/CDXC' title='ChromaDex Inc.'>CDXC</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/ZN' title='Zion Oil & Gas Inc'>ZN</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/GPRE' title='Green Plains Inc.'>GPRE</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/TANH' title='Tantech Holdings'>TANH</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/SID' title='Companhia Siderurgica Nacional'>SID</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/VOC' title='VOC Energy Trust'>VOC</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/IPHS' title='Innophos Holdings, Inc.'>IPHS</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/CBT' title='Cabot Corporation'>CBT</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/MOS' title='The Mosaic Company'>MOS</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/LTBR' title='Lightbridge Corp'>LTBR</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3262290\" data-linked=\"Energy/Materials - Top Gainers / Losers as of 2:00 pm\" data-tweet=\"$CDXC $ZN $GPRE - Energy/Materials - Top Gainers / Losers as of 2:00 pm https://seekingalpha.com/news/3262290-energy-materials-top-gainers-losers-of-2-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3262290-energy-materials-top-gainers-losers-of-2-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3262288\" data-ts=\"1493747603\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/THC\" target=\"_blank\">THC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3262288-hospital-names-put-in-biggest-rally-in-almost-two-years\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hospital names put in biggest rally in almost two years</a></h4><ul><li>Leading the way are Tenet Healthcare (<a href='https://seekingalpha.com/symbol/THC' title='Tenet Healthcare Corporation'>THC</a> <font color='green'>+22.9%</font>) and Community Health Systems (<a href='https://seekingalpha.com/symbol/CYH' title='Community Health Systems, Inc.'>CYH</a> <font color='green'>+20.4%</font>) after both reported strong Q1s. Tenet also had positive news to report with respect to its dealings with Humana and the sale of its Houston hospitals to HCA Holdings (<a href='https://seekingalpha.com/symbol/HCA' title='HCA Holdings, Inc.'>HCA</a> <font color='green'>+1.4%</font>).</li><li>Also on the move are Universal Health (<a href='https://seekingalpha.com/symbol/UHS' title='Universal Health Services Inc.'>UHS</a> <font color='green'>+3.5%</font>), Quorum Health (<a href='https://seekingalpha.com/symbol/QHC' title='Quorum Health Corporation'>QHC</a> <font color='green'>+6.5%</font>), and LifePoint Health (<a href='https://seekingalpha.com/symbol/LPNT' title='LifePoint Health, Inc.'>LPNT</a> <font color='green'>+3.4%</font>).</li><li>The Bloomberg Intelligence hospital index is<font color='green'> up 11%</font>, the most since June 2015.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3261891-tenet-healthcare-plus-14-percent-beat-humana-hca-deals\" target=\"_blank\">Tenet Healthcare +14% after beat, Humana and HCA deals</a> (May 1)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3261856-community-health-systems-beats-0_01-beats-revenue\" target=\"_blank\">Community Health Systems beats by $0.01, beats on revenue</a> (May 1)</li></ul><div class=\"tiny-share-widget\" data-id=\"3262288\" data-linked=\"Hospital names put in biggest rally in almost two years\" data-tweet=\"$THC $THC $CYH - Hospital names put in biggest rally in almost two years https://seekingalpha.com/news/3262288-hospital-names-put-in-biggest-rally-in-almost-two-years?source=tweet\" data-url=\"https://seekingalpha.com/news/3262288-hospital-names-put-in-biggest-rally-in-almost-two-years\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:53 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3262287\" data-ts=\"1493747450\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VNCE\" target=\"_blank\">VNCE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3262287-death-spiral-for-vince-holding\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Death spiral for Vince Holding</a></h4><ul><li>Shares of Vince Holding (NYSE:<a href='https://seekingalpha.com/symbol/VNCE' title='Vince Holding Corp.'>VNCE</a>) are&nbsp;<font color='red'>down another 60%</font>&nbsp;as the company slides toward bankruptcy (71% chance per <a href=\"https://www.macroaxis.com/invest/ratio/VNCE--Probability-Of-Bankruptcy\" target=\"_blank\">Macroaxis</a>).</li><li>Trading on Vince was halted earlier due to volatility.</li><li>What was a $4 stock at the beginning of 2017 now trades at $0.36.</li></ul><div class=\"tiny-share-widget\" data-id=\"3262287\" data-linked=\"Death spiral for Vince Holding\" data-tweet=\"$VNCE - Death spiral for Vince Holding https://seekingalpha.com/news/3262287-death-spiral-for-vince-holding?source=tweet\" data-url=\"https://seekingalpha.com/news/3262287-death-spiral-for-vince-holding\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:50 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3262282\" data-ts=\"1493746281\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3262282-financials-top-5-gainers-losers-of-1-30-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:30 PM</a></h4><ul><li><b>Gainers:</b>&nbsp;<a href='https://seekingalpha.com/symbol/ASBB' title='ASB Bancorp, Inc.'>ASBB</a>&nbsp;<font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/CIGI' title='Colliers International Group Inc.'>CIGI</a> <font color='green'>+8%</font>.<a href='https://seekingalpha.com/symbol/TURN' title='180 Degree Capital Corp'>TURN</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/APTS' title='Preferred Apartment Communities'>APTS</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/CCCR-OLD' title='China Commercial Credit'>CCCR-OLD</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/FANH' title='Fanhua Inc.'>FANH</a> <font color='red'>-13%</font>. WAC <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/BBD' title='Banco Bradesco, S.A.'>BBD</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/SKT' title='Tanger Factory Outlet Centers, Inc.'>SKT</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/FPO' title='First Potomac Realty Trust'>FPO</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3262282\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:30 PM\" data-tweet=\"$ASBB $CIGI $TURN - Financials - Top 5 Gainers / Losers as of 1:30 PM https://seekingalpha.com/news/3262282-financials-top-5-gainers-losers-of-1-30-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3262282-financials-top-5-gainers-losers-of-1-30-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:31 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3262279\" data-ts=\"1493745782\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MOH\" target=\"_blank\">MOH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3262279-molina-healthcare-ousts-ceo-cfo-for-performance-updated\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Molina Healthcare ousts CEO, CFO for performance (updated)</a></h4><ul>     <li>Molina Healthcare (NYSE:<a href='https://seekingalpha.com/symbol/MOH' title='Molina Healthcare, Inc.'>MOH</a>) has <a href=\"https://seekingalpha.com/pr/16818367-molina-healthcare-announces-leadership-changes\" target=\"_blank\">removed</a> its CEO Mario Molina and Chief Financial officer John Molina, effective immediately.</li>     <li>Joseph White, the company's chief accounting officer, will be interim president and CEO while the board searches for a permanent replacement. He'll also serve as chief financial officer.</li>     <li>The company made the moves due to \"disappointing financial performance.\"</li>     <li>Mario Molina and John Molina will remain on the board, though.</li>     <li>Dale Wolf, a current board member, is now non-executive chairman of the board.</li>     <li>It's also adjourned its annual meeting from tomorrow until May 10 at 1 p.m. ET.</li>     <li>Shares are <font color='green'>up 0.9%</font> on the day.</li>   <li><b>Updated 1:36 p.m.:</b> Shares have resumed trading, now <font color='green'>up 14.7%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3262279\" data-linked=\"Molina Healthcare ousts CEO, CFO for performance (updated)\" data-tweet=\"$MOH - Molina Healthcare ousts CEO, CFO for performance (updated) https://seekingalpha.com/news/3262279-molina-healthcare-ousts-ceo-cfo-for-performance-updated?source=tweet\" data-url=\"https://seekingalpha.com/news/3262279-molina-healthcare-ousts-ceo-cfo-for-performance-updated\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:23 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3262273\" data-ts=\"1493744450\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ORA\" target=\"_blank\">ORA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3262273-buyout-interest-stokes-ormat-technologies\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Buyout interest stokes Ormat Technologies</a></h4><ul><li>According to <a href=\"https://www.dealreporter.com/info/\" target=\"_blank\">Dealreporter</a>, Chinese suitors are sniffing around Ormat (<a href='https://seekingalpha.com/symbol/ORA' title='Ormat Technologies, Inc.'>ORA</a> <font color='green'>+1.1%</font>).</li></ul><div class=\"tiny-share-widget\" data-id=\"3262273\" data-linked=\"Buyout interest stokes Ormat Technologies\" data-tweet=\"$ORA - Buyout interest stokes Ormat Technologies https://seekingalpha.com/news/3262273-buyout-interest-stokes-ormat-technologies?source=tweet\" data-url=\"https://seekingalpha.com/news/3262273-buyout-interest-stokes-ormat-technologies\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3262274\" data-ts=\"1493744387\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ROAN\" target=\"_blank\">ROAN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3262274-linn-energy-to-sell-wyoming-assets-for-581m\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Linn Energy to sell Wyoming assets for $581M</a></h4><ul>     <li>Linn Energy (LNGG <font color='green'>+4.5%</font>) <a href=\"https://globenewswire.com/news-release/2017/05/02/975439/0/en/LINN-Energy-Announces-581-5-Million-Asset-Sale.html\" target=\"_blank\">agrees to sell</a> oil and gas properties in western Wyoming for $581.5M to Colorado producer Jonah Energy, which it says will allow it to focus on more lucrative assets in Oklahoma&rsquo;s SCOOP and STACK plays.</li><li>LNGG says proceeds from the sale will be  used to reduce outstanding borrowings under its revolving  credit facility and term loan.</li>     <li>Chairman Evan Lederman says the deal \"marks the first step of transitioning Linn from a conventional production-based MLP to a streamlined  growth-oriented enterprise.&rdquo;</li> </ul><div class=\"tiny-share-widget\" data-id=\"3262274\" data-linked=\"Linn Energy to sell Wyoming assets for $581M\" data-tweet=\"$ROAN - Linn Energy to sell Wyoming assets for $581M https://seekingalpha.com/news/3262274-linn-energy-to-sell-wyoming-assets-for-581m?source=tweet\" data-url=\"https://seekingalpha.com/news/3262274-linn-energy-to-sell-wyoming-assets-for-581m\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3262269\" data-ts=\"1493743930\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DAL\" target=\"_blank\">DAL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3262269-airline-stocks-follow-delta-higher\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Airline stocks follow Delta higher</a></h4><ul><li>Airline stocks are rallying after Delta reported strong traffic numbers and with some industry execs in D.C. trying to appease a House committee probing passenger rights.</li><li>Delta Air Lines (NYSE:<a href='https://seekingalpha.com/symbol/DAL' title='Delta Air Lines, Inc.'>DAL</a>) is&nbsp;<font color='green'>up 4.12%</font>&nbsp;after unit revenue rose 1% year over year in April and the carrier's load factor improved a full two percentage points.</li><li>American Airlines Group (<a href='https://seekingalpha.com/symbol/AAL' title='American Airlines Group'>AAL</a> <font color='green'>+2.7%</font>), United Continental (<a href='https://seekingalpha.com/symbol/UAL' title='United Continental Holdings, Inc'>UAL</a> <font color='green'>+3.3%</font>), Southwest Airlines (<a href='https://seekingalpha.com/symbol/LUV' title='Southwest Airlines Co.'>LUV</a> <font color='green'>+2.7%</font>) and Hawaiian Holdings (<a href='https://seekingalpha.com/symbol/HA' title='Hawaiian Holdings, Inc.'>HA</a> <font color='green'>+2.4%</font>) are other notable gainers.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3262181-airline-execs-d-c-hot-seat-today\" target=\"_blank\">Airline execs on the D.C. hot seat today</a> (May 2)</li><li>Related ETF: <a href='https://seekingalpha.com/symbol/JETS' title='U.S. Global Jets ETF'>JETS</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3262269\" data-linked=\"Airline stocks follow Delta higher\" data-tweet=\"$DAL $DAL $AAL - Airline stocks follow Delta higher https://seekingalpha.com/news/3262269-airline-stocks-follow-delta-higher?source=tweet\" data-url=\"https://seekingalpha.com/news/3262269-airline-stocks-follow-delta-higher\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:52 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3262267\" data-ts=\"1493743520\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3262267-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/ANGI' title='ANGI Homeservices Inc.'>ANGI</a> <font color='green'>+61%</font>. <a href='https://seekingalpha.com/symbol/SPAN' title='Span - America Medical Systems, Inc.'>SPAN</a> <font color='green'>+33%</font>. <a href='https://seekingalpha.com/symbol/CHGG' title='Chegg, Inc.'>CHGG</a> <font color='green'>+26%</font>. <a href='https://seekingalpha.com/symbol/THC' title='Tenet Healthcare Corporation'>THC</a> <font color='green'>+22%</font>. <a href='https://seekingalpha.com/symbol/CYH' title='Community Health Systems, Inc.'>CYH</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/BASI' title='Bioanalytical Systems, Inc.'>BASI</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/IAC' title='IAC/InterActiveCorp'>IAC</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/ASBB' title='ASB Bancorp, Inc.'>ASBB</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/HY' title='Hyster-Yale Materials Handling, Inc.'>HY</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/PBI' title='Pitney Bowes Inc.'>PBI</a> <font color='green'>+15%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/CGI' title='Celadon Group, Inc.'>CGI</a> <font color='red'>-66%</font>. <a href='https://seekingalpha.com/symbol/APHB' title='AmpliPhi Biosciences Corp.'>APHB</a> <font color='red'>-25%</font>. <a href='https://seekingalpha.com/symbol/AEZS' title='AEterna Zentaris, Inc.'>AEZS</a> <font color='red'>-21%</font>. <a href='https://seekingalpha.com/symbol/SNSS' title='Sunesis Pharmaceuticals, Inc.'>SNSS</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/AMD' title='Advanced Micro Devices, Inc.'>AMD</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/NYMX' title='Nymox Pharmaceutical Corporation'>NYMX</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/LL' title='Lumber Liquidators Holdings, Inc.'>LL</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/ARRY' title='Array BioPharma Inc.'>ARRY</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/MTBC' title='Medical Transcription Billing'>MTBC</a> <font color='red'>-13%</font>. &nbsp; <a href='https://seekingalpha.com/symbol/HSKA' title='Heska Corporation'>HSKA</a>&nbsp;<font color='red'>-12%</font></li> </ul><div class=\"tiny-share-widget\" data-id=\"3262267\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$ANGI $SPAN $CHGG - Midday Gainers / Losers https://seekingalpha.com/news/3262267-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3262267-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3262265\" data-ts=\"1493743331\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HMCBF\" target=\"_blank\">HMCBF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3262265-reuters-suitors-lining-up-for-home-capital-group-sharesplus-8_6\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Reuters: Suitors lining up for Home Capital Group; shares +8.6%</a></h4><ul><li>At least six suitors are mulling bids for the troubled Canadian lender.</li><li>The stock's&nbsp;<font color='green'>higher by 8.6%</font>&nbsp;in Toronto trade. <a href='https://seekingalpha.com/symbol/HMCBF' title='Home Capital Group Inc.'>OTCPK:HMCBF</a>&nbsp;<font color='green'>+7.05%</font></li><li>Previously: <a href=\"https://seekingalpha.com/news/3262155-home-capital-group-draws-credit-line-deposits-continue-exit\" target=\"_blank\">Home Capital Group draws on credit line as deposits continue to exit</a> (May 2)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3260066-canadian-home-lenders-tumble-alongside-home-capital-group\" target=\"_blank\">Canadian home lenders tumble alongside Home Capital Group</a> (April 26)</li></ul><div class=\"tiny-share-widget\" data-id=\"3262265\" data-linked=\"Reuters: Suitors lining up for Home Capital Group; shares +8.6%\" data-tweet=\"$HMCBF - Reuters: Suitors lining up for Home Capital Group; shares +8.6% https://seekingalpha.com/news/3262265-reuters-suitors-lining-up-for-home-capital-group-sharesplus-8_6?source=tweet\" data-url=\"https://seekingalpha.com/news/3262265-reuters-suitors-lining-up-for-home-capital-group-sharesplus-8_6\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:42 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3262258\" data-ts=\"1493741992\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MEDP\" target=\"_blank\">MEDP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3262258-medpace-holdings-plunges-28-keybanc-defends\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Medpace Holdings plunges 28%; Keybanc defends</a></h4><ul><li>Medpace Holdings (<a href='https://seekingalpha.com/symbol/MEDP' title='Medpace Holdings'>MEDP</a> <font color='red'>-28.5%</font>) missed <a href=\"https://seekingalpha.com/news/3261913-medpace-misses-0_03-beats-revenue\" target=\"_blank\">Q1 estimates last night</a>, with net new business of $93.9M down 11.8% from a year ago.</li><li>According to <a href=\"https://twitter.com/thenotablecalls\" target=\"_blank\">Notable Calls</a>, Keybanc is constructive, saying booking weakness in only temporary, and should improve markedly in H2.</li><li><a href=\"https://seekingalpha.com/article/4067842-medpace-holdings-medp-ceo-august-troendle-q1-2017-results-earnings-call-transcript?part=single\" target=\"_blank\">Check out the conference call transcript here.</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3262258\" data-linked=\"Medpace Holdings plunges 28%; Keybanc defends\" data-tweet=\"$MEDP - Medpace Holdings plunges 28%; Keybanc defends https://seekingalpha.com/news/3262258-medpace-holdings-plunges-28-keybanc-defends?source=tweet\" data-url=\"https://seekingalpha.com/news/3262258-medpace-holdings-plunges-28-keybanc-defends\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:19 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3262256\" data-ts=\"1493741352\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPLS\" target=\"_blank\">SPLS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3262256-staples-spikes-3-on-report-of-continued-p-e-interest\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Staples spikes 3% on report of continued P-E interest</a></h4><ul><li>According to Reuters, Cerberus and Sycamore remain in talks to buy Staples (<a href='https://seekingalpha.com/symbol/SPLS' title='Staples, Inc.'>SPLS</a> <font color='green'>+2.8%</font>).</li><li>Sources <a href=\"http://www.reuters.com/article/us-staples-m-a-exclusive-idUSKBN17Y1Z9?il=0\" target=\"_blank\">indicate</a> that the two firms are the front-runners to land the retailer, with other PE firms showing some hesitancy about the steep challenges of turning around results at the company.</li></ul><div class=\"tiny-share-widget\" data-id=\"3262256\" data-linked=\"Staples spikes 3% on report of continued P-E interest\" data-tweet=\"$SPLS - Staples spikes 3% on report of continued P-E interest https://seekingalpha.com/news/3262256-staples-spikes-3-on-report-of-continued-p-e-interest?source=tweet\" data-url=\"https://seekingalpha.com/news/3262256-staples-spikes-3-on-report-of-continued-p-e-interest\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:09 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3262253\" data-ts=\"1493740858\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3262253-consumer-top-gainers-losers-of-12-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/PBI' title='Pitney Bowes Inc.'>PBI</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/HY' title='Hyster-Yale Materials Handling, Inc.'>HY</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/NLS' title='Nautilus, Inc.'>NLS</a> <font color='green'>+11%</font>. COH <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/DFBG-OLD' title='Differential Brands Group Inc.'>DFBG-OLD</a> <font color='green'>+10%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/LBY' title='Libbey Inc.'>LBY</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/FDP' title='Fresh Del Monte Produce Inc.'>FDP</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/ADM' title='Archer Daniels Midland Co.'>ADM</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/SPB' title='Spectrum Brands, Inc.'>SPB</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/AXL' title='American Axle & Manufacturing Holdings, Inc.'>AXL</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3262253\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 pm\" data-tweet=\"$PBI $HY $NLS - Consumer - Top Gainers / Losers as of 12:00 pm https://seekingalpha.com/news/3262253-consumer-top-gainers-losers-of-12-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3262253-consumer-top-gainers-losers-of-12-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3262250\" data-ts=\"1493739825\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ADM\" target=\"_blank\">ADM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3262250-archer-danielsminus-8-after-missing-q1-expectations\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Archer Daniels -8% after missing Q1 expectations</a></h4><ul><li>Archer Daniels Midland (<a href='https://seekingalpha.com/symbol/ADM' title='Archer Daniels Midland Co.'>ADM</a> <font color='red'>-8%</font>) plunges after reporting weaker than expected <a href=\"https://seekingalpha.com/news/3262041-archer-daniels-midland-misses-0_02-misses-revenue\" target=\"_blank\">Q1 earnings</a> and revenues, although the company did enjoy operating profit growth across most of its segments.</li><li>ADM says Q1 sales in its agricultural services unit - which buys,  sells, stores, ships and trades grains and oilseeds - <a href=\"http://www.reuters.com/article/us-archer-daniels-results-idUSKBN17Y160\" target=\"_blank\">rose 5% Y/Y</a> to $6.81B and operating profit jumped 15.8% to $88M; North America grain  showed strong results amid healthy demand for U.S. commodities, but international merchandising  declined to a lack of opportunities and unfavorable mark-to-market  effects.</li><li>Q1 earnings for the corn processing unit gained 33% Y/Y to $171M, helped by strong U.S. ethanol export demand, and oilseeds processing profit added 20%, lifted by improved softseed  margins in Europe and North America and increased revenues in Asia.</li></ul><div class=\"tiny-share-widget\" data-id=\"3262250\" data-linked=\"Archer Daniels -8% after missing Q1 expectations\" data-tweet=\"$ADM - Archer Daniels -8% after missing Q1 expectations https://seekingalpha.com/news/3262250-archer-danielsminus-8-after-missing-q1-expectations?source=tweet\" data-url=\"https://seekingalpha.com/news/3262250-archer-danielsminus-8-after-missing-q1-expectations\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:43 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3262247\" data-ts=\"1493738221\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TWTR\" target=\"_blank\">TWTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3262247-twitterplus-3_2-cuban-says-recently-bought-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Twitter +3.2% as Cuban says he&#39;s recently bought shares</a></h4><ul>   <li>Twitter (NYSE:<a href='https://seekingalpha.com/symbol/TWTR' title='Twitter, Inc.'>TWTR</a>) -- coming off a nice <font color='green'>goosing of 6.4%</font> yesterday amid a dozen <a href=\"https://seekingalpha.com/news/3261956-twitter-plus-6_4-percent-announces-several-video-streaming-deals\" target=\"_blank\">new streaming-video deals</a> --  has <font color='green'>moved up another 3.2%</font> in recent minutes as Mark Cuban says he's bought shares recently.</li>    <li>\"They've finally gotten their act together, on artificial intelligence,\" Cuban <a href=\"https://twitter.com/carlquintanilla/status/859425150390984704\" target=\"_blank\">says on CNBC</a>.</li>    <li>Twitter's now at $18.09.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3262247\" data-linked=\"Twitter +3.2% as Cuban says he&#39;s recently bought shares\" data-tweet=\"$TWTR - Twitter +3.2% as Cuban says he&#39;s recently bought shares https://seekingalpha.com/news/3262247-twitterplus-3_2-cuban-says-recently-bought-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3262247-twitterplus-3_2-cuban-says-recently-bought-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>35&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3262246\" data-ts=\"1493738061\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BHC\" target=\"_blank\">BHC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3262246-valeant-pharma-considering-name-change-ceo-says\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Valeant Pharma considering a name change, CEO says</a></h4><ul>     <li>Valeant Pharmaceuticals (VRX <font color='green'>+4.1%</font>) is <a href=\"https://www.bloomberg.com/news/articles/2017-05-02/valeant-ponders-a-name-change-to-try-and-escape-past-reputation\" target=\"_blank\">considering a name change</a>, as it seeks to move away from the bad publicity that has dogged the company amid harsh criticism of its business practices and future prospects.</li>     <li>No final decision has been made but the company is &ldquo;very serious&rdquo; in considering the idea, CEO&nbsp;Joe Papa says at VRX's annual shareholders meeting.</li><li>Papa also says VRX in on pace to meet its target to pay down $5B of debt from divestiture proceeds and free cash flow by February 2018.</li></ul><div class=\"tiny-share-widget\" data-id=\"3262246\" data-linked=\"Valeant Pharma considering a name change, CEO says\" data-tweet=\"$BHC - Valeant Pharma considering a name change, CEO says https://seekingalpha.com/news/3262246-valeant-pharma-considering-name-change-ceo-says?source=tweet\" data-url=\"https://seekingalpha.com/news/3262246-valeant-pharma-considering-name-change-ceo-says\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>120&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3262244\" data-ts=\"1493737930\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UNH\" target=\"_blank\">UNH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3262244-unitedhealth-quickly-off-1-on-report-of-government-claims\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">UnitedHealth quickly off 1% on report of government claims</a></h4><ul><li>U.S. charges UnitedHealth (NYSE:<a href='https://seekingalpha.com/symbol/UNH' title='UnitedHealth Group Inc.'>UNH</a>) mischarged Medicare programs, reads a headline across Bloomberg.</li><li>Developing ... will update as details come in.</li><li><strong>Update at 11:25 ET:</strong> The DOJ, reports Bloomberg, has intervened in a lawsuit filed by a former employee of Senior Care Action Network Health Plan alleging UnitedHealth obtained inflated payments based on false information about the health of beneficiaries enrolled in UHC of California - the company's largest Medicare Advantage plan. Shares are now&nbsp;<font color='red'>down 2%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3262244\" data-linked=\"UnitedHealth quickly off 1% on report of government claims\" data-tweet=\"$UNH - UnitedHealth quickly off 1% on report of government claims https://seekingalpha.com/news/3262244-unitedhealth-quickly-off-1-on-report-of-government-claims?source=tweet\" data-url=\"https://seekingalpha.com/news/3262244-unitedhealth-quickly-off-1-on-report-of-government-claims\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:12 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3262242\" data-ts=\"1493737475\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FCAU\" target=\"_blank\">FCAU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3262242-auto-roundup-letdown-in-detroit-new-high-out-of-palo-alto\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Auto roundup: Letdown in Detroit, new high out of Palo Alto</a></h4><ul> <li>All three Detroit automakers are down sharply after the trio posted weak U.S. sales for April. FCA (<a href='https://seekingalpha.com/symbol/FCAU' title='Fiat Chrysler Automobiles NV'>FCAU</a> <font color='red'>-5.1%</font>), Ford (<a href='https://seekingalpha.com/symbol/F' title='Ford Motor Company'>F</a> <font color='red'>-3.9%</font>) and General Motors (<a href='https://seekingalpha.com/symbol/GM' title='General Motors Company'>GM</a> <font color='red'>-3%</font>) now face some tricky inventory management, according to industry watchers.</li> <li>Ward's notes that the industry will have four straight months of inventory of over 4M units for the first time since 2004. \"With flat retail demand and inventory at record levels, manufacturers will continue to face a difficult choice between maintaining elevated incentives or making production cuts,\" observes J.D. Power's Deirdre Borrego.</li> <li>Auto parts and auto retailer stocks are lower in reaction to the slower-than-anticipated pace of U.S. sales. Notable decliners include American Axle &amp; Manufacturing (<a href='https://seekingalpha.com/symbol/AXL' title='American Axle & Manufacturing Holdings, Inc.'>AXL</a> <font color='red'>-7.2%</font>), BorgWarner (<a href='https://seekingalpha.com/symbol/BWA' title='BorgWarner Inc.'>BWA</a> <font color='red'>-4.7%</font>), Lear Corporation (<a href='https://seekingalpha.com/symbol/LEA' title='Lear Corporation'>LEA</a> <font color='red'>-4.6%</font>), Visteon (<a href='https://seekingalpha.com/symbol/VC' title='Visteon Corporation'>VC</a> <font color='red'>-2.7%</font>), Tenneco (<a href='https://seekingalpha.com/symbol/TEN' title='Tenneco Inc.'>TEN</a> <font color='red'>-1.8%</font>), Superior Industries (<a href='https://seekingalpha.com/symbol/SUP' title='Superior Industries International Inc.'>SUP</a> <font color='red'>-3.2%</font>), Delphi Automotive (<a href='https://seekingalpha.com/symbol/DLPH' title='Delphi Technologies PLC'>DLPH</a> <font color='red'>-2.3%</font>), Gentex (<a href='https://seekingalpha.com/symbol/GNTX' title='Gentex Corporation'>GNTX</a> <font color='red'>-2.8%</font>), Tower International (<a href='https://seekingalpha.com/symbol/TOWR' title='Tower International, Inc.'>TOWR</a> <font color='red'>-0.7%</font>), Gentherm (<a href='https://seekingalpha.com/symbol/THRM' title='Gentherm Incorporated'>THRM</a> <font color='red'>-1.6%</font>), Cooper-Standard (<a href='https://seekingalpha.com/symbol/CPS' title='Cooper-Standard Holdings Inc.'>CPS</a> <font color='red'>-1.9%</font>), Motorcar Parts of America (<a href='https://seekingalpha.com/symbol/MPAA' title='Motorcar Parts of America, Inc.'>MPAA</a> <font color='red'>-2.2%</font>), Sonic Automotive (<a href='https://seekingalpha.com/symbol/SAH' title='Sonic Automotive Inc.'>SAH</a> <font color='red'>-4.8%</font>), Group 1 Automotive (<a href='https://seekingalpha.com/symbol/GPI' title='Group 1 Automotive Inc.'>GPI</a> <font color='red'>-4.4%</font>), AutoNation (<a href='https://seekingalpha.com/symbol/AN' title='AutoNation Inc'>AN</a> <font color='red'>-3.3%</font>), Lithia Motors (<a href='https://seekingalpha.com/symbol/LAD' title='Lithia Motors, Inc.'>LAD</a> <font color='red'>-3.4%</font>), Asbury Automotive (<a href='https://seekingalpha.com/symbol/ABG' title='Asbury Automotive Group, Inc.'>ABG</a> <font color='red'>-3.7%</font>), CarMax (<a href='https://seekingalpha.com/symbol/KMX' title='CarMax Group'>KMX</a> <font color='red'>-0.9%</font>) and Magna International (<a href='https://seekingalpha.com/symbol/MGA' title='Magna International Inc.'>MGA</a> <font color='red'>-2%</font>).</li><li>Toyota (<a href='https://seekingalpha.com/symbol/TM' title='Toyota Motor Corporation'>TM</a> <font color='green'>+0.9%</font>) and Nissan (<a href='https://seekingalpha.com/symbol/NSANY' title='Nissan Motor Co., Ltd. ADR'>OTCPK:NSANY</a> <font color='green'>+0.6%</font>) are modestly higher on the day.</li> <li>Tesla (NASDAQ:<a href='https://seekingalpha.com/symbol/TSLA' title='Tesla, Inc.'>TSLA</a>), which trades like a tech stock apart from industry news in the opinion of some, is <font color='red'>down 0.84%</font> on the day - but did crank out a new all-time high of $327.66 earlier. Tomorrow is <a href=\"https://seekingalpha.com/news/3261892-tesla-rips-another-gain-earnings-approach\" target=\"_blank\">earnings day</a> for the Palo Alto-based company.</li> <li>Related ETF: <a href='https://seekingalpha.com/symbol/CARZ' title='First Trust NASDAQ Global Auto Index ETF'>CARZ</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3262242\" data-linked=\"Auto roundup: Letdown in Detroit, new high out of Palo Alto\" data-tweet=\"$FCAU $FCAU $F - Auto roundup: Letdown in Detroit, new high out of Palo Alto https://seekingalpha.com/news/3262242-auto-roundup-letdown-in-detroit-new-high-out-of-palo-alto?source=tweet\" data-url=\"https://seekingalpha.com/news/3262242-auto-roundup-letdown-in-detroit-new-high-out-of-palo-alto\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>93&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3262241\" data-ts=\"1493737458\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAVXF\" target=\"_blank\">AAVXF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3262241-abivax-soars-on-hiv-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Abivax soars on HIV results</a></h4><ul><li>Phase IIa results show ABX464 has potential to become a &ldquo;key functional cure element&rdquo; for HIV, &nbsp;Abivax (<a href='https://seekingalpha.com/symbol/AAVXF' title='Abivax SA'>OTCPK:AAVXF</a>) <a href=\"http://www.abivax.com/en/news-events/press-releases/479-first-ever-evidence-of-treatment-induced-reduction-in-hiv-reservoirs.html\" target=\"_blank\">says in a statement</a>.</li><li>Safety was the primary endpoint in the trial and ABX464 was well tolerated and there were no severe adverse events in the treatment group. Amongs evaluable patients (4 placebo and 14 ABX464-treated patients), a reduction in viral DNA copies/mPBMCs was observed in 7/14 treated patients (mean change of -40%, ranging from -27% to -67%) and no responders were observed in the placebo group. Responders were defined as patients who had a decrease greater than 25% in total HIV DNA in PBMCs and a reduction of at least 50 copies.</li><li>&ldquo;This is the first time we see a signal with any therapeutic candidate that it may be possible to reduce HIV reservoirs in patients,&rdquo;&nbsp;said Professor Linos Vandekerckhove, Head HIV Cure Research Center at the Department of Internal Medicine, at the University of Ghent, Belgium, a principal investigator involved in the study.&nbsp;&lsquo;&rsquo;Now we are looking forward to learn how this drug can be optimized to be part of a multitarget approach to further reduce the viral reservoir.&rdquo;</li><li>Shares <font color='green'>+135%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3262241\" data-linked=\"Abivax soars on HIV results\" data-tweet=\"$AAVXF - Abivax soars on HIV results https://seekingalpha.com/news/3262241-abivax-soars-on-hiv-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3262241-abivax-soars-on-hiv-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3262228\" data-ts=\"1493737319\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3262228-healthcare-top-5-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 am</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/SPAN' title='Span - America Medical Systems, Inc.'>SPAN</a> <font color='green'>+33%</font>. <a href='https://seekingalpha.com/symbol/THC' title='Tenet Healthcare Corporation'>THC</a> <font color='green'>+24%</font>. <a href='https://seekingalpha.com/symbol/CYH' title='Community Health Systems, Inc.'>CYH</a> <font color='green'>+21%</font>. <a href='https://seekingalpha.com/symbol/HLTH' title='Nobilis Health Corp.'>HLTH</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/LMAT' title='LeMaitre Vascular, Inc.'>LMAT</a> <font color='green'>+8%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/SNSS' title='Sunesis Pharmaceuticals, Inc.'>SNSS</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/NYMX' title='Nymox Pharmaceutical Corporation'>NYMX</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/AEZS' title='AEterna Zentaris, Inc.'>AEZS</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/RXDX' title='Ignyta, Inc.'>RXDX</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/HSKA' title='Heska Corporation'>HSKA</a> <font color='red'>-12%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3262228\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 am\" data-tweet=\"$SPAN $THC $CYH - Healthcare - Top 5 Gainers / Losers as of 11:00 am https://seekingalpha.com/news/3262228-healthcare-top-5-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3262228-healthcare-top-5-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3262238\" data-ts=\"1493736821\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NLY\" target=\"_blank\">NLY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3262238-mortgage-reits-lower-across-board-after-agnc-capital-raise\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mortgage REITs lower across the board after AGNC capital raise</a></h4><ul><li>Trading above book value for the first time in years, AGNC Investment last night hit <a href=\"https://seekingalpha.com/news/3262191-agnc-investment-nearly-3-percent-pricing-secondary\" target=\"_blank\">the capital raise button</a>. It's<font color='red'> lower by 3.1%</font>&nbsp;in morning trade.</li><li>A rally in mREITs (<a href='https://seekingalpha.com/symbol/REM' title='iShares Mortgage Real Estate Capped ETF'>REM</a> is&nbsp;<font color='green'>up 19% Y/Y</font>, and&nbsp;<font color='green'>11%&nbsp;</font>YTD) combined with stable to falling book values has the entire sector near or above book value, so investors are probably viewing AGNC's share sale as the start of a trend, rather than a one-off. Q1 results need to be gotten out of the way first.</li><li>Annaly Capital (<a href='https://seekingalpha.com/symbol/NLY' title='Annaly Capital Management, Inc.'>NLY</a> <font color='red'>-1.5%</font>), Chimera Investment (<a href='https://seekingalpha.com/symbol/CIM' title='Chimera Investment Corporation'>CIM</a> <font color='red'>-3.8%</font>), CYS Investments (<a href='https://seekingalpha.com/symbol/CYS' title='CYS Investments, Inc.'>CYS</a> <font color='red'>-1.3%</font>), Invesco Mortgage (<a href='https://seekingalpha.com/symbol/IVR' title='Invesco Mortgage Capital Inc.'>IVR</a> <font color='red'>-1.4%</font>), MTGE Investment (<a href='https://seekingalpha.com/symbol/MTGE' title='MTGE Investment Corp.'>MTGE</a> <font color='red'>-1.4%</font>), New York Mortgage (<a href='https://seekingalpha.com/symbol/NYMT' title='New York Mortgage Trust, Inc.'>NYMT</a> <font color='red'>-1.7%</font>), Capstead (<a href='https://seekingalpha.com/symbol/CMO' title='Capstead Mortgage Corporation'>CMO</a> <font color='red'>-2%</font>), Western Asset (<a href='https://seekingalpha.com/symbol/WMC' title='Western Asset Mortgage Capital Corporation'>WMC</a> <font color='red'>-1.7%</font>), MFA Financial (<a href='https://seekingalpha.com/symbol/MFA' title='MFA Financial, Inc.'>MFA</a> <font color='red'>-1%</font>).</li><li>The only name in the green is Armour Residential (<a href='https://seekingalpha.com/symbol/ARR' title='ARMOUR Residential REIT, Inc.'>ARR</a> <font color='green'>+1.5%</font>) after <a href=\"https://seekingalpha.com/news/3261881-big-bounce-performance-armour-residential-q1-shares-less-5-percent-discount-book\" target=\"_blank\">reporting a big Q1</a> last night. Even this habitual underperformer and dividend-cutter is trading at just the thinnest discount to book value.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/MORL' title='UBS ETRACS Monthly Pay 2x Leveraged Mortgage REIT ETN'>MORL</a>, <a href='https://seekingalpha.com/symbol/REM' title='iShares Mortgage Real Estate Capped ETF'>REM</a>, <a href='https://seekingalpha.com/symbol/MORT' title='VanEck Vectors Mortgage REIT Income ETF'>MORT</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3262238\" data-linked=\"Mortgage REITs lower across the board after AGNC capital raise\" data-tweet=\"$NLY $REM $NLY - Mortgage REITs lower across the board after AGNC capital raise https://seekingalpha.com/news/3262238-mortgage-reits-lower-across-board-after-agnc-capital-raise?source=tweet\" data-url=\"https://seekingalpha.com/news/3262238-mortgage-reits-lower-across-board-after-agnc-capital-raise\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3262236\" data-ts=\"1493736552\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FDP\" target=\"_blank\">FDP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3262236-on-fresh-del-montes-q1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Fresh Del Monte&#39;s Q1</a></h4><ul>     <li>Fresh Del Monte Produce (<a href='https://seekingalpha.com/symbol/FDP' title='Fresh Del Monte Produce Inc.'>FDP</a> <font color='red'>-8%</font>)&nbsp;reports Banana segment sales fell 2.9% to $445.1M in <a href=\"https://seekingalpha.com/pr/16817080-fresh-del-monte-produce-inc-reports-first-quarter-2017-financial-results\" target=\"_blank\">Q1</a> due to lower net sales in all of the Company's regions.</li>     <li>Other fresh produce segment sales up 5.3% to $506.2M primarily due to higher net sales in the Company's avocado and fresh-cut product lines.</li>     <li>Prepared food segment sales improved 3.2% to $81.1M.</li>     <li>Revenue by geography:&nbsp;North America: $601.4M (+2.4%);&nbsp;Europe: $174.5M (+0.6%); Middle East: $122.9M (-0.9%);&nbsp;Asia: $113.2M (-1.8%);&nbsp;Other: $20.4M (+14%).</li>     <li>Gross margin rate declined 420 bps to 9.6%.</li>     <li>SG&amp;A expense rate flat at 4.6%.</li>     <li>Operating margin rate down 370 bps to 5.2%.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3262236\" data-linked=\"More on Fresh Del Monte&#39;s Q1\" data-tweet=\"$FDP - More on Fresh Del Monte&#39;s Q1 https://seekingalpha.com/news/3262236-on-fresh-del-montes-q1?source=tweet\" data-url=\"https://seekingalpha.com/news/3262236-on-fresh-del-montes-q1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:49 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3262234\" data-ts=\"1493736123\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RDUS\" target=\"_blank\">RDUS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3262234-radius-health-down-another-4_7-on-tymlos-launch-concerns\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Radius Health down another 4.7% on Tymlos launch concerns</a></h4><ul><li>Radius (NASDAQ:<a href='https://seekingalpha.com/symbol/RDUS' title='Radius Health, Inc.'>RDUS</a>)<font color='red'> tumbled nearly 10%</font>&nbsp;yesterday after an earnings call discussion of its newly-approved osteoporosis drug Tymlos. Shares are&nbsp;<font color='red'>down another 4.7%&nbsp;</font>today.</li><li>Goldman analyst Salveen Richter pressed for how Tymlos' net price would compare to Eli Lilly's Forteo, with management saying those details would be out in coming days and weeks.</li><li>Richter also wanted to know how Radius planned to differentiate its treatment from Forteo given the label for Tymlos didn't include comparator data and had a boxed warning.</li><li>\"Pricing and reimbursement, as well as heightening competition, pose challenges,\" says Cowen's&nbsp;Chris Shibutani, throwing in the towel on his Outperform rating. He also sees challenges from Amgen's and UCB's competing experimental drug maybe hitting the market in the near-term.</li><li>Source: Bloomberg</li></ul><div class=\"tiny-share-widget\" data-id=\"3262234\" data-linked=\"Radius Health down another 4.7% on Tymlos launch concerns\" data-tweet=\"$RDUS - Radius Health down another 4.7% on Tymlos launch concerns https://seekingalpha.com/news/3262234-radius-health-down-another-4_7-on-tymlos-launch-concerns?source=tweet\" data-url=\"https://seekingalpha.com/news/3262234-radius-health-down-another-4_7-on-tymlos-launch-concerns\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>20&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3262233\" data-ts=\"1493735983\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TXRH\" target=\"_blank\">TXRH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3262233-texas-roadhouse-cruises-to-new-high\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Texas Roadhouse cruises to new high</a></h4><ul> <li>Texas Roadhouse (NASDAQ:<a href='https://seekingalpha.com/symbol/TXRH' title='Texas Roadhouse, Inc.'>TXRH</a>)&nbsp;<font color='green'>jumps 10.1%</font>&nbsp;after posting better-than-anticipated Q1 results. Shares carved out a new all-time high of $51.22 before falling back a bit.</li> <li>Analysts aren't enthused about jumping into the restaurant stock at current levels, noting labor margins and food costs are likely to stay under pressure (via Bloomberg).</li> <li>Price target actions: RBC to $53 from $49, Wells Fargo to $46-$48 from $43-$45, Deutsche Bank to $49 from $45, Jefferies to $40 from $38.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3261820-texas-roadhouse-beats-0_03-beats-revenue\" target=\"_blank\">Texas Roadhouse beats by $0.03, beats on revenue</a> (May 1)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3262233\" data-linked=\"Texas Roadhouse cruises to new high\" data-tweet=\"$TXRH - Texas Roadhouse cruises to new high https://seekingalpha.com/news/3262233-texas-roadhouse-cruises-to-new-high?source=tweet\" data-url=\"https://seekingalpha.com/news/3262233-texas-roadhouse-cruises-to-new-high\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:39 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3262232\" data-ts=\"1493735863\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PFE\" target=\"_blank\">PFE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3262232-deal-needed-prescription-for-pfizer-s-lackluster-sales-analysts-say\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Deal needed as prescription for Pfizer\u2019s lackluster sales, analysts say</a></h4><ul>     <li>Pfizer's (<a href='https://seekingalpha.com/symbol/PFE' title='Pfizer Inc.'>PFE</a> <font color='red'>-1.5%</font>) <a href=\"https://seekingalpha.com/news/3262131-pfizer-q1-revenues-2-percent-non-gaap-eps-3-percent-reaffirms-guidance\" target=\"_blank\">disappointing Q1 sales</a> of its major medicines spark suggestions that the company <a href=\"https://www.bloomberg.com/news/articles/2017-05-02/pfizer-s-lackluster-sales-show-need-of-a-deal-to-revive-growth\" target=\"_blank\">needs to make some deals</a> to boost its growth prospects.</li>     <li>Sales of breast cancer drug Ibrance rose more than 58% Y/Y to $679M but fell short of the analyst consensus estimate of $682M, while sales of rheumatoid arthritis drug Xeljanz and pneumonia vaccine Prevnar also missed expectations.</li>     <li>Overall Q1 revenue fell for the second straight quarter to $12.78B, ~$300M short of estimates, hurt in part by the stronger dollar and fewer selling days compared with a year earlier.</li>     <li>\"Key franchises came in well below expectations, <a href=\"http://www.reuters.com/article/us-pfizer-results-idUSKBN17Y14L\" target=\"_blank\">raising concerns</a> about Pfizer's ability to grow in the absence of M&amp;A,\" Goldman Sachs analysts say.</li></ul><div class=\"tiny-share-widget\" data-id=\"3262232\" data-linked=\"Deal needed as prescription for Pfizer\u2019s lackluster sales, analysts say\" data-tweet=\"$PFE - Deal needed as prescription for Pfizer\u2019s lackluster sales, analysts say https://seekingalpha.com/news/3262232-deal-needed-prescription-for-pfizer-s-lackluster-sales-analysts-say?source=tweet\" data-url=\"https://seekingalpha.com/news/3262232-deal-needed-prescription-for-pfizer-s-lackluster-sales-analysts-say\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:37 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3262230\" data-ts=\"1493735539\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WKHS\" target=\"_blank\">WKHS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3262230-workhorse-breaks-higher-after-ryder-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Workhorse breaks higher after Ryder deal</a></h4><ul> <li>Workhorse (NASDAQ:<a href='https://seekingalpha.com/symbol/WKHS' title='Workhorse Group Inc.'>WKHS</a>) <font color='green'>jumps 13%</font> to $2.26 after the company announces a 10-year strategic partnership with Ryder. Shares of Workhorse are still down 68% YTD.</li>  <li>The company's electric delivery vans are in use in the U.S. by customers that include UPS, FedEx, Cintas and Alpha Baking.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3262230\" data-linked=\"Workhorse breaks higher after Ryder deal\" data-tweet=\"$WKHS - Workhorse breaks higher after Ryder deal https://seekingalpha.com/news/3262230-workhorse-breaks-higher-after-ryder-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3262230-workhorse-breaks-higher-after-ryder-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3262225\" data-ts=\"1493735011\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BP\" target=\"_blank\">BP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3262225-oil-stockpiles-rebalance-to-five-year-norm-opec-extends-cuts-bp-cfo-says\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oil stockpiles rebalance to five-year norm if OPEC extends cuts, BP CFO says</a></h4><ul>     <li>An extension of oil production cuts into H2 would help <a href=\"http://www.reuters.com/article/us-bp-results-oil-idUSKBN17Y19Q?il=0\" target=\"_blank\">rebalance the oil market</a>, bringing global crude inventories back to a five-year average by the end of the year and support prices at ~$55/bbl, BP (<a href='https://seekingalpha.com/symbol/BP' title='BP p.l.c.'>BP</a> <font color='green'>+2.1%</font>) CFO Brian Gilvary says.</li>     <li>\"If the OPEC cuts get rolled into the second half of the year, that will underpin oil prices. If they don't get rolled into the second half of the year, we will continue to see more volatility,\" Gilvary says.</li>     <li>\"From BP's perspective, we're managing things around $50-55 a barrel, [and] that's probably the range we would expect for the rest of the year,\" the CFO says.</li>     <li>Oil stockpiles in industrialized nations were slightly more than 3B barrels at the end of February, ~330M barrels above the five-year average but with the market showing more balance, the International Energy Agency said last month.</li></ul><div class=\"tiny-share-widget\" data-id=\"3262225\" data-linked=\"Oil stockpiles rebalance to five-year norm if OPEC extends cuts, BP CFO says\" data-tweet=\"$BP - Oil stockpiles rebalance to five-year norm if OPEC extends cuts, BP CFO says https://seekingalpha.com/news/3262225-oil-stockpiles-rebalance-to-five-year-norm-opec-extends-cuts-bp-cfo-says?source=tweet\" data-url=\"https://seekingalpha.com/news/3262225-oil-stockpiles-rebalance-to-five-year-norm-opec-extends-cuts-bp-cfo-says\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3262224\" data-ts=\"1493734870\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HLT\" target=\"_blank\">HLT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3262224-on-hilton-worldwides-q1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Hilton Worldwide&#39;s Q1</a></h4><ul>     <li>Hilton Worldwide (<a href='https://seekingalpha.com/symbol/HLT' title='Hilton Worldwide Holdings'>HLT</a> <font color='green'>+3.4%</font>)&nbsp;reports&nbsp;system-wide RevPAR rose 3% in <a href=\"https://seekingalpha.com/pr/16817097-hilton-reports-first-quarter-results-raises-full-year-outlook\" target=\"_blank\">Q1</a>, due to increased occupancy.</li>     <li>U.S. comparable RevPAR +2.5%.</li>     <li>Franchise fees +8.5% to $294M.</li>     <li>Owned and leased hotels&nbsp;revenue fell 6% to $300M.</li>     <li>System-wide occupancy rate up 160 bps to 70.9%.</li>     <li>Adjusted EBITDA increased 15.5% to $424M.</li>     <li>Operating margin rate grew 210 bps to 12.8%.</li>     <li><b>Q2 Guidance:&nbsp;</b>System-wide RevPAR: +1% to +3%;&nbsp;Adjusted EBITDA:&nbsp;$490M to $510M;&nbsp;Management and franchise fees: +7% to +9%; Net income: $156M to $173M; Adjusted EPS: $0.47 to $0.51.</li>     <li><b>FY2017 Guidance</b>: System-wide RevPAR: +1% to +3%; Ownership RevPAR:&nbsp;+1% to +3%;&nbsp;Adjusted EBITDA: $1.86B to $1.9B;&nbsp;Management and franchise fees: +7% to +9%; Net income: $529M to $554M; Adjusted EPS: $1.73 to $1.81; Capex: $150M to $200M.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3262224\" data-linked=\"More on Hilton Worldwide&#39;s Q1\" data-tweet=\"$HLT - More on Hilton Worldwide&#39;s Q1 https://seekingalpha.com/news/3262224-on-hilton-worldwides-q1?source=tweet\" data-url=\"https://seekingalpha.com/news/3262224-on-hilton-worldwides-q1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:21 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3262222\" data-ts=\"1493734387\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/W\" target=\"_blank\">W</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3262222-m-watch-wayfair-seen-wal-mart-target\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">M&amp;A watch: Wayfair seen as Wal-Mart target</a></h4><ul> <li>Buckingham Research calls Wayfair (<a href='https://seekingalpha.com/symbol/W' title='Wayfair'>W</a> <font color='green'>+2.7%</font>) an \"extremely\" attractive target for Wal-Mart (<a href='https://seekingalpha.com/symbol/WMT' title='Walmart Inc.'>WMT</a> <font color='green'>+0.4%</font>) in a fresh note to clients.</li> <li>The investment firm's price target of $57 on Wayfair is a new Street high, according to Bloomberg. Shares of Wayfair are already up 38% YTD amid takeover buzz.</li> <li>Wal-Mart has been on a formidable M&amp;A tear in the e-commerce sector that doesn't appear to be slowing down.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3262222\" data-linked=\"M&amp;A watch: Wayfair seen as Wal-Mart target\" data-tweet=\"$W $W $WMT - M&amp;A watch: Wayfair seen as Wal-Mart target https://seekingalpha.com/news/3262222-m-watch-wayfair-seen-wal-mart-target?source=tweet\" data-url=\"https://seekingalpha.com/news/3262222-m-watch-wayfair-seen-wal-mart-target\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:13 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3262218\" data-ts=\"1493734023\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FCAU\" target=\"_blank\">FCAU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3262218-big-drop-for-fca-after-u-s-sales-disappoint\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Big drop for FCA after U.S. sales disappoint</a></h4><ul>     <li>Fiat Chrysler Automobiles (<a href='https://seekingalpha.com/symbol/FCAU' title='Fiat Chrysler Automobiles NV'>FCAU</a> <font color='red'>-4.8%</font>) unit sales -7%</a> to 177,441 vs. -5.8% forecast by Kelley Blue Book.</li> <li>Fleet sales fell 21% Y/Y to 30,650 units as part of a corporate strategy to lower sales to the daily rental segment.</li>     <li>Brand sales growth: Fiat -18% to 2,539; Chrysler -3% to 17,309; Jeep -17% to 68,879 Dodge -3% to 39,445; Ram +5% to 47,327; Alfa Romeo +1047% to 677.</li> <li>Sales of Ram P/U trucks increased a solid 8% to 43,321 units, while the new Pacific van saw sales top 10K.</li>  <li>FCA's average transaction price was up 3.3% Y/Y to $36,353.</li> <li>YTD U.S. sales -8% to 691,527 units.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3262218\" data-linked=\"Big drop for FCA after U.S. sales disappoint\" data-tweet=\"$FCAU - Big drop for FCA after U.S. sales disappoint https://seekingalpha.com/news/3262218-big-drop-for-fca-after-u-s-sales-disappoint?source=tweet\" data-url=\"https://seekingalpha.com/news/3262218-big-drop-for-fca-after-u-s-sales-disappoint\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:07 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3262212\" data-ts=\"1493733437\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EQT\" target=\"_blank\">EQT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3262212-eqt-corpplus-3-gets-analyst-love\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EQT Corp. +3%, gets some analyst love</a></h4><ul><li>EQT Corp. (NYSE:<a href='https://seekingalpha.com/symbol/EQT' title='EQT Corporation'>EQT</a>)&nbsp;<font color='green'>+3%</font>&nbsp;in early trading to $59.89.</li><li>Stifel says the selloff to EQT&rsquo;s flat Q2 forecast is overdone. Reiterates Buy rating and boosts PT to $81 from $63. Notes \"higher well productivity from increased type curves and forward gas strips continuing to grind higher.\"</li><li>Separately, EQT scored a \"New Buy Idea\" from Off Wall Street with a similar $81.60 PT, or about 40% implied upside.</li><li>EQT is down ~7% since <a href=\"https://seekingalpha.com/news/3260445-eqt-misses-0_04-beats-revenue\" target=\"_blank\">reporting an EPS miss</a>&nbsp;on&nbsp;April 27. Cowen said to expect selling pressure after disappointing guidance, though continues to favor the company&rsquo;s long-term growth view.</li></ul><div class=\"tiny-share-widget\" data-id=\"3262212\" data-linked=\"EQT Corp. +3%, gets some analyst love\" data-tweet=\"$EQT - EQT Corp. +3%, gets some analyst love https://seekingalpha.com/news/3262212-eqt-corpplus-3-gets-analyst-love?source=tweet\" data-url=\"https://seekingalpha.com/news/3262212-eqt-corpplus-3-gets-analyst-love\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3262199\" data-ts=\"1493732629\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GM\" target=\"_blank\">GM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3262199-gm-slumps-after-u-s-sales-fall-6\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GM slumps after U.S. sales fall 6%</a></h4><ul>     <li>General Motors (NYSE:<a href='https://seekingalpha.com/symbol/GM' title='General Motors Company'>GM</a>) unit sales -5.8%</a> to 237,388 units vs. -0.7% expected by Kelley Blue Book. There was one less selling day in April compared to last year.</li>        <li>GM ended the month with 100 days supply vs. 98 days at the end of March</li> <li>Shares of GM <font color='red'>-2.25%</font> to $33.44.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3262199\" data-linked=\"GM slumps after U.S. sales fall 6%\" data-tweet=\"$GM - GM slumps after U.S. sales fall 6% https://seekingalpha.com/news/3262199-gm-slumps-after-u-s-sales-fall-6?source=tweet\" data-url=\"https://seekingalpha.com/news/3262199-gm-slumps-after-u-s-sales-fall-6\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:43 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>31&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3262198\" data-ts=\"1493732621\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FPO\" target=\"_blank\">FPO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3262198-first-potomacminus-5_8-after-stifel-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">First Potomac -5.8% after Stifel downgrade</a></h4><ul><li>via Bloomberg</li><li>Stifel's John Guinee notes net asset value \"erosion\" at the D.C.-area office property owner.</li><li>A significant equity infusion north of $200M is a necessity for basic operations, growth, and to get institutional investors interested, he says.</li><li>\"We are assuming 'rope-a-dope' M&amp;A conversations have occurred.\"</li><li>He downgrades to Sell from Hold. The price target is $9.50.</li><li><a href='https://seekingalpha.com/symbol/FPO' title='First Potomac Realty Trust'>FPO</a>&nbsp;<font color='red'>-5.8%</font>&nbsp;to $10.60.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3260948-first-potomac-realty-trust-reports-q1-results\" target=\"_blank\">First Potomac Realty Trust reports Q1 results</a> (April 27)</li></ul><div class=\"tiny-share-widget\" data-id=\"3262198\" data-linked=\"First Potomac -5.8% after Stifel downgrade\" data-tweet=\"$FPO - First Potomac -5.8% after Stifel downgrade https://seekingalpha.com/news/3262198-first-potomacminus-5_8-after-stifel-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3262198-first-potomacminus-5_8-after-stifel-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:43 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3262192\" data-ts=\"1493732138\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ETSY\" target=\"_blank\">ETSY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3262192-etsyplus-3_5-targeted-investor-for-strategic-review\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Etsy +3.5%, targeted by investor for strategic review</a></h4><ul><li>Etsy (NASDAQ:<a href='https://seekingalpha.com/symbol/ETSY' title='Etsy, Inc.'>ETSY</a>) is <font color='green'>+3.5%</font> on news it's being targeted by hedge fund Black-and-White Capital LP, which is urging it to explore strategic alternatives including a possible sale.</li><li>Black-and-White, which says it&nbsp;owns&nbsp;about 2% of Etsy, is publicly releasing its proposals and criticisms after months of private talks. The firm highlighted Etsy&rsquo;s need to re-accelerate revenue growth and reduce bloated operating costs.</li><li>Source: Bloomberg</li></ul><div class=\"tiny-share-widget\" data-id=\"3262192\" data-linked=\"Etsy +3.5%, targeted by investor for strategic review\" data-tweet=\"$ETSY - Etsy +3.5%, targeted by investor for strategic review https://seekingalpha.com/news/3262192-etsyplus-3_5-targeted-investor-for-strategic-review?source=tweet\" data-url=\"https://seekingalpha.com/news/3262192-etsyplus-3_5-targeted-investor-for-strategic-review\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3262191\" data-ts=\"1493732119\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AGNC\" target=\"_blank\">AGNC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3262191-agnc-investment-down-nearly-3-after-pricing-secondary\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AGNC Investment down nearly 3% after pricing secondary</a></h4><ul><li>The company sold 24.5M shares for expected gross proceeds of $507.2M, suggesting a price per share of $20.70 each. The underwriters have an option to buy another 3.675M shares at that price.</li><li><a href='https://seekingalpha.com/symbol/AGNC' title='AGNC Investment Corp.'>AGNC</a><font color='red'> -2.7%&nbsp;</font>to $20.60 in early action.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3261867-agnc-investment-hits-capital-raise-button\" target=\"_blank\">AGNC Investment hits the capital raise button</a> (May 1)</li></ul><div class=\"tiny-share-widget\" data-id=\"3262191\" data-linked=\"AGNC Investment down nearly 3% after pricing secondary\" data-tweet=\"$AGNC - AGNC Investment down nearly 3% after pricing secondary https://seekingalpha.com/news/3262191-agnc-investment-down-nearly-3-after-pricing-secondary?source=tweet\" data-url=\"https://seekingalpha.com/news/3262191-agnc-investment-down-nearly-3-after-pricing-secondary\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:35 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3262182\" data-ts=\"1493731207\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPAN\" target=\"_blank\">SPAN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3262182-span-america-to-be-bought-savaria-for-29-share\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Span-America to be bought by Savaria for $29/share</a></h4><ul><li>Span-America Medical (NASDAQ:<a href='https://seekingalpha.com/symbol/SPAN' title='Span - America Medical Systems, Inc.'>SPAN</a>) <font color='green'>+35.3%</font> premarket after <a href=\"https://seekingalpha.com/pr/16816531-span-america-medical-systems-inc-agrees-acquired-savaria-corporation\" target=\"_blank\">agreeing to be acquired</a> by Savaria Corp. (<a href='https://seekingalpha.com/symbol/SISXF' title='Savaria Corp.'>OTCPK:SISXF</a>) for $29/share, a 33% premium to last Friday's closing stock price.</li><li>Savaria designs, manufactures, distributes and installs       accessibility equipment, such as stair lifts for straight and curved       stairs, vertical and inclined wheelchair lifts, elevators for home and       commercial use, as well as patient lifts.</li></ul><div class=\"tiny-share-widget\" data-id=\"3262182\" data-linked=\"Span-America to be bought by Savaria for $29/share\" data-tweet=\"$SPAN $SPAN $SISXF - Span-America to be bought by Savaria for $29/share https://seekingalpha.com/news/3262182-span-america-to-be-bought-savaria-for-29-share?source=tweet\" data-url=\"https://seekingalpha.com/news/3262182-span-america-to-be-bought-savaria-for-29-share\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:20 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3262180\" data-ts=\"1493731135\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3262180-premarket-gainers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/ANGI' title='ANGI Homeservices Inc.'>ANGI</a> <font color='green'>+54%</font>&nbsp;on <a href='https://seekingalpha.com/symbol/IAC' title='IAC/InterActiveCorp'>IAC</a>&nbsp;<a href=\"https://seekingalpha.com/news/3261915-angies-list-jumps-44-percent-report-iac-deal-offer\" target=\"_blank\">deal</a> offer.</li>     <li><a href='https://seekingalpha.com/symbol/MOC' title='Command Security Corporation'>MOC</a> <font color='green'>+28%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3262146-command-security-corp-plus-40-percent-80m-contract\" target=\"_blank\">announcing</a> $80M contract.</li>     <li><a href='https://seekingalpha.com/symbol/NXTD' title='NXT-ID Inc.'>NXTD</a> <font color='green'>+21%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3262136-nxt-id-reports-preliminary-q1-results\" target=\"_blank\">announcing</a> preliminary result.</li>     <li><a href='https://seekingalpha.com/symbol/BDSI' title='BioDelivery Sciences International, Inc.'>BDSI</a> <font color='green'>+17%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/16817204-biodelivery-sciences-announces-approval-bunavail-induction-buprenorphine-treatment-opioid\" target=\"_blank\">announcing</a>&nbsp;the FDA broadened the indication for its opioid dependency treatment BUNAVAIL to include induction.</li>     <li><a href='https://seekingalpha.com/symbol/THC' title='Tenet Healthcare Corporation'>THC</a> <font color='green'>+14%</font>&nbsp;on reporting Q1 <a href=\"https://seekingalpha.com/news/3261857-tenet-healthcare-beats-0_24-misses-revenue\" target=\"_blank\">result</a>.</li>     <li><a href='https://seekingalpha.com/symbol/CHGG' title='Chegg, Inc.'>CHGG</a> <font color='green'>+12%</font>&nbsp;on reporting Q1&nbsp;<a href=\"https://seekingalpha.com/news/3261832-chegg-beats-0_03-beats-revenue\" target=\"_blank\">result</a>.</li>     <li><a href='https://seekingalpha.com/symbol/IAC' title='IAC/InterActiveCorp'>IAC</a> <font color='green'>+12%</font>&nbsp;on <a href='https://seekingalpha.com/symbol/ANGI' title='ANGI Homeservices Inc.'>ANGI</a>&nbsp;<a href=\"https://seekingalpha.com/news/3261915-angies-list-jumps-44-percent-report-iac-deal-offer\" target=\"_blank\">deal</a>&nbsp;offer.</li>     <li><a href='https://seekingalpha.com/symbol/CMI' title='Cummins Inc.'>CMI</a> <font color='green'>+7%</font>&nbsp;on reporting Q1 <a href=\"https://seekingalpha.com/news/3262083-cummins-beats-0_56-beats-revenue\" target=\"_blank\">result</a>.</li>     <li><a href='https://seekingalpha.com/symbol/TNXP' title='Tonix Pharmaceuticals Holding Corp.'>TNXP</a> <font color='green'>+7%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3262163-tonix-plus-6_4-percent-premarket-patent-issuance\" target=\"_blank\">patent</a> issuance.</li>     <li>COH <font color='green'>+6%</font>&nbsp;on reporting Q1 <a href=\"https://seekingalpha.com/news/3262025-coach-beats-0_02-misses-revenue\" target=\"_blank\">result</a>.</li>     <li><a href='https://seekingalpha.com/symbol/PQ' title='PetroQuest Energy Inc.'>PQ</a> <font color='green'>+6%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/EXEL' title='Exelixis, Inc.'>EXEL</a> <font color='green'>+5%</font>&nbsp;on reporting Q1 <a href=\"https://seekingalpha.com/news/3261826-exelixis-beats-0_06-beats-revenue\" target=\"_blank\">result</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3262180\" data-linked=\"Premarket Gainers as of 9:05 am\" data-tweet=\"$ANGI $IAC $MOC - Premarket Gainers as of 9:05 am https://seekingalpha.com/news/3262180-premarket-gainers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3262180-premarket-gainers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3262177\" data-ts=\"1493730949\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3262177-premarket-losers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/CGI' title='Celadon Group, Inc.'>CGI</a>&nbsp;<font color='red'>-45%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3262152-celadon-minus-30-percent-prior-financial-reports-longer-relied-upon\" target=\"_blank\">announcing</a> prior financial reports unreliable.</li><li><a href='https://seekingalpha.com/symbol/SNSS' title='Sunesis Pharmaceuticals, Inc.'>SNSS</a>&nbsp;<font color='red'>-18%&nbsp;</font>on <a href=\"https://seekingalpha.com/pr/16816720-sunesis-pharmaceuticals-announces-withdrawal-european-marketing-authorization-application-maa\" target=\"_blank\">withdrawing</a> leukemia drug marketing application.</li><li><a href='https://seekingalpha.com/symbol/HLIT' title='Harmonic Inc.'>HLIT</a>&nbsp;<font color='red'>-17%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3261819-harmonic-misses-0_09-misses-revenue\" target=\"_blank\">Q1 earnings</a> miss.</li><li><a href='https://seekingalpha.com/symbol/AMD' title='Advanced Micro Devices, Inc.'>AMD</a>&nbsp;<font color='red'>-12%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3261848-advanced-micro-devices-eps-revenue-line\" target=\"_blank\">Q1 earnings</a>.</li><li><a href='https://seekingalpha.com/symbol/MTBC' title='Medical Transcription Billing'>MTBC</a> <font color='red'>-13%</font>.</li><li><a href='https://seekingalpha.com/symbol/AEZS' title='AEterna Zentaris, Inc.'>AEZS</a> <font color='red'>-11%</font>.</li><li>CLNT <font color='red'>-7%</font>.</li><li><a href='https://seekingalpha.com/symbol/LL' title='Lumber Liquidators Holdings, Inc.'>LL</a> <font color='red'>-6%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3262005-lumber-liquidators-misses-0_71-beats-revenue\" target=\"_blank\">Q1 earnings</a>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3262177\" data-linked=\"Premarket Losers as of 9:05 am\" data-tweet=\"$CGI $SNSS $HLIT - Premarket Losers as of 9:05 am https://seekingalpha.com/news/3262177-premarket-losers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3262177-premarket-losers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3262170\" data-ts=\"1493729906\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NLS\" target=\"_blank\">NLS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3262170-nautilus-sees-second-half-strength-adds-buyback-firepower\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nautilus sees second-half strength, adds buyback firepower</a></h4><ul> <li>Nautilus (NYSE:<a href='https://seekingalpha.com/symbol/NLS' title='Nautilus, Inc.'>NLS</a>) <a href=\"https://seekingalpha.com/pr/16816593-nautilus-inc-reports-results-first-quarter-2017\" target=\"_blank\">approves</a> an additional $15M in buyback firepower to bring its total share repurchase authorization to $25M.</li> <li>Management issued a positive outlook on the firm's conference call, noting the company is positioned for double-digit growth in the back of the year.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3261834-nautilus-eps-line-beats-revenue\" target=\"_blank\">Nautilus EPS in-line, beats on revenue</a> (May 1)</li> <li><a href=\"https://seekingalpha.com/article/4067631-nautilus-nls-ceo-bruce-cazenave-q1-2017-results-earnings-call-transcript\" target=\"_blank\">Nautilus earnings call transcript</a></li> <li>Shares of Nautilus are unchanged in light premarket trading.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3262170\" data-linked=\"Nautilus sees second-half strength, adds buyback firepower\" data-tweet=\"$NLS - Nautilus sees second-half strength, adds buyback firepower https://seekingalpha.com/news/3262170-nautilus-sees-second-half-strength-adds-buyback-firepower?source=tweet\" data-url=\"https://seekingalpha.com/news/3262170-nautilus-sees-second-half-strength-adds-buyback-firepower\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:58 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3262168\" data-ts=\"1493729890\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMI\" target=\"_blank\">CMI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3262168-cumminsplus-7-following-big-q1-beat-upside-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cummins +7% following big Q1 beat, upside guidance</a></h4><ul>     <li>Cummins (NYSE:<a href='https://seekingalpha.com/symbol/CMI' title='Cummins Inc.'>CMI</a>)&nbsp;<font color='green'>+6.7%</font> premarket after easily beating <a href=\"https://seekingalpha.com/news/3262083-cummins-beats-0_56-beats-revenue\" target=\"_blank\">Q1 earnings</a> expectations and raising its full-year outlook for revenues.</li>     <li>CMI says Q1 revenues rose 7% Y/Y to $4.6B, citing stronger demand from construction and mining customers and higher sales from a distributor acquisition in Q4; Q1 EBIT was $566M, or 12.3% of sales, an increase from $484M, or 11.3% of sales       a year ago.</li>     <li>For FY 2017, CMI now sees revenues rising 4%-7% from prior guidance of flat to down 5%, implying $18.2B-$18.7B, vs. $17.3B analyst consensus estimate, and expects EBIT of 11.75%-12.5% of sales, up from 11%-11.5%.</li>      </ul><div class=\"tiny-share-widget\" data-id=\"3262168\" data-linked=\"Cummins +7% following big Q1 beat, upside guidance\" data-tweet=\"$CMI - Cummins +7% following big Q1 beat, upside guidance https://seekingalpha.com/news/3262168-cumminsplus-7-following-big-q1-beat-upside-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3262168-cumminsplus-7-following-big-q1-beat-upside-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3262164\" data-ts=\"1493729578\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SHPG\" target=\"_blank\">SHPG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3262164-shire-plc-q1-revenues-up-109-non-gaap-eps-up-14-shares-ahead-2-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shire PLC Q1 revenues up 109%; non-GAAP EPS up 14%; shares ahead 2% premarket</a></h4><ul><li>Shire PLC (<a href='https://seekingalpha.com/symbol/SHPG' title='Shire PLC'>SHPG</a>) <a href=\"https://seekingalpha.com/pr/16817240-shire-delivers-strong-q1-2017-revenue-growth-advancing-late-stage-pipeline\" target=\"_blank\">Q1 results</a>: Revenues: $3,572.3M (+109.0%); Operating Income: $497.1M (-8.6%); Net Income: $354.8M (-13.4%); EPS: $1.23 (-42.0%); Non-GAAP EPS: $3.63 (+13.8%); Quick Assets: $369M (-30.2%); CF Ops: $459.1M (+17.9%).</li><li>Genetic Diseases: $696.2M (13.5%); Neuroscience: $653.3M (+3.7%); Hematology: $870.9M; Immunology: $676.2M; Internal Medicine: $418.8M (+9.1%); Oncology: $58.3M; Ophthalmology: $38.6M.</li><li><strong>2017 Guidance</strong>: Total product sales: $14.5B - 14.8B; Royalties &amp; other revenues: $600M - 700M; GAAP EPS: $6.95 - 7.55; Non-GAAP EPS: $14.60 - 15.20.</li><li>Shares are up&nbsp;<font color='green'>2%</font>&nbsp;premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3262164\" data-linked=\"Shire PLC Q1 revenues up 109%; non-GAAP EPS up 14%; shares ahead 2% premarket\" data-tweet=\"$SHPG - Shire PLC Q1 revenues up 109%; non-GAAP EPS up 14%; shares ahead 2% premarket https://seekingalpha.com/news/3262164-shire-plc-q1-revenues-up-109-non-gaap-eps-up-14-shares-ahead-2-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3262164-shire-plc-q1-revenues-up-109-non-gaap-eps-up-14-shares-ahead-2-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:52 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3262163\" data-ts=\"1493729560\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TNXP\" target=\"_blank\">TNXP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3262163-tonixplus-6_4-premarket-on-patent-issuance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tonix +6.4% premarket on patent issuance</a></h4><ul><li>Tonix Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/TNXP' title='Tonix Pharmaceuticals Holding Corp.'>TNXP</a>)&nbsp;is <font color='green'>+6.4%</font> premarket after <a href=\"https://seekingalpha.com/pr/16817264-tonix-pharmaceuticals-announces-issuance-u-s-patent-tnxminus-102-sl-composition-formulation\" target=\"_blank\">announcing</a> the U.S. Patent and Trademark Office issued a patent &ldquo;Eutectic Formulations of Cyclobenzaprine Hydrochloride and Amitriptyline Hydrochloride&rdquo; which claims the composition and manufacture of a unique formulation that characterizes its PTSD treatment TNX-102 SL.</li><li>The &lsquo;408 patent is expected to provide Tonix with U.S. market exclusivity until 2034.</li><li>TNX-102 SL is an investigational new drug and has not been approved for any indication.</li></ul><div class=\"tiny-share-widget\" data-id=\"3262163\" data-linked=\"Tonix +6.4% premarket on patent issuance\" data-tweet=\"$TNXP - Tonix +6.4% premarket on patent issuance https://seekingalpha.com/news/3262163-tonixplus-6_4-premarket-on-patent-issuance?source=tweet\" data-url=\"https://seekingalpha.com/news/3262163-tonixplus-6_4-premarket-on-patent-issuance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:52 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3262161\" data-ts=\"1493729413\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVGO\" target=\"_blank\">AVGO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3262161-new-iphone-to-support-wireless-charging-broadcom-jpmorgan\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">New iPhone to support wireless charging by Broadcom - JPMorgan</a></h4><ul><li>Broadcom's (NASDAQ:<a href='https://seekingalpha.com/symbol/AVGO' title='Broadcom Limited'>AVGO</a>) new wireless charging chip <a href=\"http://www.cnbc.com/2017/05/02/new-iphone-to-pack-wireless-charging.html\" target=\"_blank\">will be included in the next</a> iPhone, says the team at JPMorgan.</li><li>Exactly which models will have this functionality isn't specified, but a report earlier this year from KGI Securities said all of the new iPhones - iPhone 8, iPhone 7s, and iPhone 7s Plus will offer it.</li><li>Also not specified is which wireless charging standard the new iPhone chips will support, but Qi and PMA are the main competitors, and Broadcom sells chips supporting both.</li><li>The \"wireless charging win\" could mean another $500M-$600M of annualized revenues for Broadcom's wireless business, says JPMorgan.</li><li>AVGO&nbsp;<font color='green'>higher by 1.3%</font>&nbsp;premarket</li></ul><div class=\"tiny-share-widget\" data-id=\"3262161\" data-linked=\"New iPhone to support wireless charging by Broadcom - JPMorgan\" data-tweet=\"$AVGO - New iPhone to support wireless charging by Broadcom - JPMorgan https://seekingalpha.com/news/3262161-new-iphone-to-support-wireless-charging-broadcom-jpmorgan?source=tweet\" data-url=\"https://seekingalpha.com/news/3262161-new-iphone-to-support-wireless-charging-broadcom-jpmorgan\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:50 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3262159\" data-ts=\"1493729278\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WSTC\" target=\"_blank\">WSTC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3262159-west-corpminus-9_2-premarket-on-reports-of-lowered-price-tag\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">West Corp -9.2% premarket on reports of lowered price tag</a></h4><ul><li>West Corp (NASDAQ:<a href='https://seekingalpha.com/symbol/WSTC' title='West Corporation'>WSTC</a>) is<font color='red'> -9.2%</font> premarket following a <a href=\"http://www.reuters.com/article/us-west-m-a-apollo-global-idUSKBN17X2I1\" target=\"_blank\">news report</a> buyout firm Apollo Global (NYSE:<a href='https://seekingalpha.com/symbol/APO' title='Apollo Global Management, LLC'>APO</a>)&nbsp;is trying to convince it to accept a $2B acquisition offer.</li><li>Apollo has prevailed in an auction for West Corp and is in advanced negotiations to acquire the company.</li><li>However, Apollo's latest offer values West Corp at least two dollars/share below Monday's close of $26.71.</li><li>West Corp's services include conferencing and collaboration, unified communications, alerts and notifications, emergency communications, business process outsourcing and telephony/interconnect services.</li></ul><div class=\"tiny-share-widget\" data-id=\"3262159\" data-linked=\"West Corp -9.2% premarket on reports of lowered price tag\" data-tweet=\"$WSTC $WSTC $APO - West Corp -9.2% premarket on reports of lowered price tag https://seekingalpha.com/news/3262159-west-corpminus-9_2-premarket-on-reports-of-lowered-price-tag?source=tweet\" data-url=\"https://seekingalpha.com/news/3262159-west-corpminus-9_2-premarket-on-reports-of-lowered-price-tag\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3262156\" data-ts=\"1493728811\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BDSI\" target=\"_blank\">BDSI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3262156-biodelivery-sciencesplus-11_4-premarket-on-broadening-of-bunavail-mandate\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BioDelivery Sciences +11.4% premarket on broadening of BUNAVAIL mandate</a></h4><ul><li>BioDelivery Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/BDSI' title='BioDelivery Sciences International, Inc.'>BDSI</a>) <font color='green'>+11.4%</font> premarket after <a href=\"https://seekingalpha.com/pr/16817204-biodelivery-sciences-announces-approval-bunavail-induction-buprenorphine-treatment-opioid\" target=\"_blank\">announcing</a> the FDA broadened the indication for its opioid dependency treatment BUNAVAIL to include induction, or the initial process undertaken when a patient is transitioned from the abused opioid responsible for their addiction to the dose of BUNAVAIL which is intended to provide relief from cravings and withdrawal.</li><li>Previously, the indication for BUNAVAIL only covered the maintenance treatment phase of opioid dependence treatment.</li></ul><div class=\"tiny-share-widget\" data-id=\"3262156\" data-linked=\"BioDelivery Sciences +11.4% premarket on broadening of BUNAVAIL mandate\" data-tweet=\"$BDSI - BioDelivery Sciences +11.4% premarket on broadening of BUNAVAIL mandate https://seekingalpha.com/news/3262156-biodelivery-sciencesplus-11_4-premarket-on-broadening-of-bunavail-mandate?source=tweet\" data-url=\"https://seekingalpha.com/news/3262156-biodelivery-sciencesplus-11_4-premarket-on-broadening-of-bunavail-mandate\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}